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SUMMARY
Periods of Performance
A contract from the NASA Technology Utilization Office creating a
Biomedical Applications Team at the University of Wisconsin-Madison was
first awarded in mid-1974. Since that time, the UW-BAT has operated
continuously under successive contracts.
The present report covers the time span of July 1, 1976 through
December 31, 1978, a 30-month interval broken into two distinct periods.
The first 18 months, from July 1, 1976 through December 31, 1977 was
devoted to full-scale normal operations of a BAT as described in Section
II of this report. The last 12 months, covering the period January 1,
1978 through December 31, 1978, was devoted solely to a project specifically
authorized under a contract extension. Period I and Period II will be
used herein to refer to these separate periods.
Work accomplished under the first 18-month period will be discussed
in Sections III and IV of this report. Work carried out during the 12-month
extension period will be covered in Section V.
Period I Summary
As a consequence of carrying out normal BAT operations during this
period, a total of 21 new problem statements were prepared for distribution
to NASA field centers. A list of these, beginning with UW-30, can be found
in Appendix A. Of the total under consideration during the period, 16
i lllr
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problem statements were dropped from further consideration. These are
identified in Section IV under "Inactivated Problem Statements" and brief
details are given concerning the inactivation in ea-,h case. We were left
with 21 active problem statements to carry over into the new year.
Section III of the report contains complete statements of each of the
remaining active problems.
Aside from problem statement activity, the Team worked to help
commercialize several devices produced under separate RTOP funding. Two
of these, the JPL Burn Analysis System and the GSFC Lixiscope were
demonstrated to potential manufacturers at conferences arranged by members
of the UW-BAT. A third, the JPL Proctosigmcidoscope was reviewed by a
Team member in preparation for possible further development of the device
but plans to continue work on the device were dropped by the center.
A number of special reports were produced in response to requests
from Headquarters and field centers, and these are identified in an
annotated listing at the end of Section IV.
Period II Summary
The contract period was extended by 12 months, specifically to
carry out a project on the needs of the elderly. During this 12-month
period (which fully overlapped a sequentially awarded contract to support
normal BAT operations at the University of Wisconsin), a special effort
was put forth to analyze needs of the elderly in terms of opportunities for
solution available through the NASA TU program.
The project was organized into seven discrete tasks. These are shown
in Section V of this report, followed by a running synopsis of work
accomplished under the contract extension.
SECTION II
THE NASA BIOMEDICAL APPLICATIONS TEAM PROGRAM
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THE NASA BIOMEDICAL APPLICATIONS TEAM PROGRAM
INTRODUCTION
The Technology Utilization Program
Biomedical Applications Teams are an important element of the overall
NASA Technology Utilization Office. The Technology Utilization Office was
established in 1962 for the following purposes:
1. To increase the return on the national investment in aeronautical
and space programs by helping to bring about additional uses of
the knowledge gained in these programs.
2. To shorten the time from development of new knowledge to its
dissemination and effective utilization.
3. To aid the movement of new knowledge across organizational,
disciplinary, and regional boundaries.
4. To help develop better methods for communicating and applying
government-generated knowledge to private industry.
The Office has organized its activities on a nationwide basis (transfer net-
work) to promote effective utilization of the vast amounts of new technology
and other technical information generated by aerospace research and develop-
meat programs.
PROGRAM (GENERAL)
The Biomedical Applications Teams
Biomedical Applications Teams (BATeams) were established by NASA in 1966
for the specific purpose of transferring aerospace technology to the solution
of biomedical problems. Basically, each BATeam acts as an interface (broker)
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between the medical profession, rehabilitation centers, mission agencies,
manufacturer, and NASA scientists and engineers. Team members met with
investigators in the medical and biological sciences, physicians, and
medical specialists, to define significant technological problems. This
methodology demands that specific medical needs are identified and defined
through direct contact with potential users of aerospace technology. Only
those problems are considered which meet the following criteria:
1. No ready solution is available through commercial medical
instrument manufacturers. That is to say that the new or wproved
products are probably made possible only through the use of NASA
technology.
2. The problem can be defined in terms such that an aerospace
related technology could be applicable to a solution.
3. Solution of the problem would make a significant contribution
to medical research or clinical medical practice. The emphasis,
therefore, is on identifying and commercializing those applications
of NASA technology that are significant commercialization oppor-
tunities or provide major medical breakthrough.
There are three Biomedical Applications Teams established at the following
institutions:
1. Stanford University School of Medicine
Cardiology Division
Biomedical Technology Transfer
701 Welch Road - Suite 3303
Palo Alto, California 94304
2. Research Triangle Institute
P.O. Box 12194
Research Triangle Park, North Carolina 21709
3. Advisory Center for Medical Technology and Systems
University of Wisconsin
1500 Johnson Drive
Madison, Wisconsin 53706
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Technology Transfer Process
The team "technology" itself is very broad, including both hardware
and software, as well as the engineering expertise that has been a part of
aerospace projects. There are many different ways in which technology
developed through the space program can be applied or transferred to
solving biomedical problems. No single approach to transferring technology
to medicine is applicable to all medical problems. The approach is
adapted to the particular problem and institution involved. However, the
general procedure followed by the Biomedical Applications Teams consists of
four basic steps:
1. Jentification of Commercialization Opportunities
Z. Screening of Commercialization Opportunities
3. Development of Commercialization Strategy
4. Implementation of Commercialization Strategy
These steps are described in the following paragraphs.
PROGRAM (SPECIFIC)
Identification of Commercialization Opportunities - In order to identify
commercialization opportunities, the Team serves as an active interface
between medical investigal.rs and the body of scientific and technical
knowledge that has resulted from this nation's aerospace research program.
The Team attempts to carefully define the technological needs facing the
medical community and to identify relevant aerospace technology to solve
those needs. The needs are those encountered in clinical and rehabilitation
medicine and medical research programs in major clinics and medical schools and
in the National Institutes of Health. The Team actively engages in the
identification of these needs through direct contact with the clinical
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rehabilitation and medical research staffs. The objective is to define
precisely and accurately the characteristics of the technology required to
solve the needs. In many cases, following the characterization of the required
technology, it is obvious that the need should not be considered by the Team.
The "should not" reasons could include the following: (1) the need can be
solved using commercially available equipment; (2 1 the reed cannot be solved,
so that an entirely different approach is indicated; (3) the real problem is
medical and not technical in nature; (4) the possible solutions would have
little probability of being commercialized; and (S) the requirements cannot
be specified because insufficient information exists.
After the problem is defined, a BATeam member confers with the problem
originator. Clarification of technological aspects of the problem leads to
the formulation of a "Problem Statement." Besides defining the problem in
greater detail, the Problem Statement answers the following questions:
1. ~fiat medical specialty is Involvrd?
2. bow has this problem been solved in the past?
3. What presently available commercial equipment is applicable?
4. What broad medical impact will solution of the problem have?
S. Can the technological solution offered by NASA be readily made
commercially available?
Aerospace technology that may be relevant to the solution of a need is
identified by three approaches. First, a manual (or computer) search is
made of the aerospace information bank. These searches are made at one of
NASA's six Industrial Applications Centers (IAC). On-line computer searchers
utilize the NASA Scientific and Technical information Facility in BWI Airport,
Maryland. The information that can be accessed through the infermation bank
consists of more than one million documents, articles, and translations that
have been abstracted in the Scientific and Technical Aerospace Reports (STAR).
The International Aerospace Abstracts (IAA), Computer Program Abstracts,
Tech Briefs, and in many other puSlicatioLes Second, the Team contacts
individuals at the NASA Field Centers who are likely to have a good overview
of all work being done, which is related to the requirements of a specific
medical need. Third, problem statements are circulated in a highll selective
manner with the distribution being determined by the Team, Technology
Utilization Officers (TUO) at the NASA Field Centers, and other individuals
at the Field Centers.
All potentially relevant technology that is identified by the search
procedures is evaluated by the Team to determine whether a potential solution
to a specific need has been found. Those items of technology that represent
potential solutions to needs are presented to problem originators along with
available supporting data and information. Any required re-engineering (and
the detrils of implementing the potential solutions) are discussed with the
problem originator.
The problem originator and the Team must then work together to evaluate
potential solutions. Their decision to implement a proposed solution will
depend upon a number of factors: (1) their assessment of the technical
validity of the proposed potential solution; (2) the medical applicability
of the proposed solution; (3) consideration of the cost and time r.;rcessary
to complete the implementation; and (4) appreciation of factors which would
contribute to later development of a commercially attractive device. They
should evaluate the appropriateness of the proposed solutions and select
one solution for further action. Then, the team prepares a commercializa-
tion package which describes the solution, the medical need, the patent
status. and various pertinent aspects of the potential market. This package
is used to aid in the identification of a manufacturer.
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Those solutions that have been selected by the above procedures are
subjected to the second step--screening of commercialization opportunities.
Screening of Commercialization Opportunities - Effective screening of
commercializatiou opportunities is at least as important to the success of
the Biomedical Applications Team Program as any of the operational steps.
For it is through this screening process that the Team identifies those
commercialization opportunities that have a high probability of being
commercialized. In addition, much of the data used in the development of
commercialization strategy is accumulated during this process. Currently,
the following criteria are being utilized to screen commercialization
opportunities:
(a) The solution uses NASA technology or expertise.
(b) The solution provides an innovative improvement in treatment
or diagnosis, or it results in a reduction in cost of health care.
(c) The solution will have a significant impact on the medical field,
and the character of that impact will be positive.
(d) The market size is adequate for the necessary capital risks, and
the solution can be manufactured at a cost which will permit
penetration of this market.
(e) A latent demand exists for the solution, or a demand can be
created using pertinent marketing techniques.
(f) The potential manufacturers are identified who are willing to
join a NASA-Industrial-Medical Team to commercialize the solution
and who will agree to sharing the costs of this development effort.
(g) The existing distribution patterns and organizations that will
move the product from the manufacturer to the potential user, if
not an integral part of the manufacturer's organization, are
identified.
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(h) The funding for the necessary development, engineering evaluation,
and marketing necessary to commercialize this solution have been
tentatively identified, with all or most of the funds coming from
sources other than NASA.
Commercialization opportunities that do not satisfy these criteria are
rejected or placed into a category entitled "Institutional" (more than 50%
co-funded by a mission agency) or "Demonstration" (more than 60% co-funded by
a mission agency). In all cases that are not coupled with a manufacturer,
NASA conducts a market study to learn more about the potential for widespread
use. Those that do are classified as having a high probability of being
commercialized and are dor:umented in a commercialization opportunity report.
The Team now initiates the third step--development of commercialization
strategy.
Development of Commercialization Strategy - Studies have clearly shown
that the manufacturer must be inv3lved early in the product development
procedure. Therefore, the Team immediately undertakes the identification of
a suitable manufacturer. Copies of the commercialization package, which
describes the commercialization opportunity, are forwarded to suitable
manufacturers. An officer for each of these manufacturers is personally
interviewed. thus, favoritism is avoided. Once the manufacturer is
identified, the NASA-Industrial-Medical Team is formed. The role of each
member is defined and any agreements which are found necessary, such as
licensing arrangements, are negotiated. This newly formed NASA-Industrial-
Medical Team, with the Biomedical Applications Team now acting as a consultant
and coordinator (broker), must create the product development and marketing
plans. The costs of carrying out these plans are estimated, and it is agreed
how much of this cost each member will underwrite. If costs cannot be covered
by the NASA-Industrial-Medical Team, sources for the necessary additional funds
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must be identified. Possible sources are such organizations as the National
Institutes of Health, the Rehabilitation Services Administration, the
Veterans Administration, and others.
The distribution of the finished product can pose a serious problem.
It must be carefully considered in the marketing plan, since many manufacturers
do not have their own product distribution and product maintenance systems.
These, needs must be met. They may require the addition of a fourth member to
the NASA-Industrial-Medical Team. Unfortunately, the cost of such a distribu-
tion system can make it economically impossible to market the NASA device.
Therefore, it is best to learn this before the expenditure of much time,
money, and effort.
Two other factors which must be considered are: (1) the special medical
testing required by such organizations as the Food and Drug Administration; and
(2) the effort to develop a new market. Both of these needs are usually
adequately provided for if care has been exercised in the selection of the
manufacturer: If properly qualified, the manufacturer will have extensive
experience in both of these areas. If either factor is not considered in the
selection of the manufacturer, the commercialization effort will almost
certainly fail.
Funding sources must be identified. Ideally, NASA funding will not be
required. Rather, all or most of the funding will normally be provided by
the government agency that has the primary responsibility for the particular
area of medical need. As an example, when the medical need involves some
cancer treatment technique, the government agency to provide most of the
funding would be the National Cancer Institute. If NASA funding is needed and
can be justified, the Team will work closely with the involved NASA Field
Center to prepare the necessary Research and Technology Objectives and Plans
(RTOP) for submission to NASA Headquarters. However, before submission of the
RTOP, the commercialization strategy has been completed and the commercializa-
tion opportunity has becn classified as a potential commercialization: (1) the
:NASA-Industrial-Medical Team has been formed; (2) the development and marketing
plans have been completed; (3) the sources of co-funding have been identified;
and (G) the potential commercialization report has been prepared and dis-
tributed. Descriptions of this strategy become an integral part of the RTOP.
the formal approval of the RTOP by NASA Headquarters or, in the case
where an RTOP is not required, the approval of the coamiercialization strategy
by the NASA-Industrial-Medical Team will initiate the final step in the Team
methodology-implementation of commercialization strategy.
Implementation of Commercialization Strategy - In this final step, the
role of the Team is one of monitoring, coordinating, and reporting. However,
this Team activity is vital to the success of the commercialization effort.
By carefully monitoring and coordinating the activities of individual members
of the NASA-Industrial-Medical Team, minor problems can be prevented from
becoming major obstacles. In addition, the project overview held by the
Team, plus knowledge of the technology transfer process, gives the Team
considerable insight as to the possible sources of difficulties. Thus, the
Team can help guide the project around these problem areas.
Reports and documentation are an integral part of the Team methodology;
they are involved at most steps in the transfer of technology. The step
involving the implementation of commercialization strategy is no exception.
Periodic status reports must be issued to keep all interested parties
informed. Upon completion of a commercialization, the Team must prepare a
commercialization report. The resulting reports and documentation facilitate
a later analysis of the entire technology application process.
w
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TERMS OFTEN USED
In the Biomedical Applications Team Program, a number of terms have
evolved that describe the elements and processes in this program. Because
of their number and unfamiliarity to many readers, these terms are listed and
defined for reference.
Biomedical Applications Team (Team) - The Team is a multidisciplinary
group of engineers and scientists engaged in the activities of identifying
the technological needs in medicine and rehabilitation and the appropriate
aerospace technology to solve those needs with the specific objective of
effecting the commercialization of the resulting solutions. The methodology
used by the Team involves: (1) Identifying Commercialization Opportunities -
select and define significant medical technological needs and the appropriate
solutions that use NASA-developed technology; (2) Screening Commercialization
Opport^-nities - identify those commercialization opportunities that have a
high probability of being commercialized; (3) Developing Commercialization
Strategy - form a NASA-Industrial-Medical Team, and create the necessary
development and marketing plans, including identifying the necessary funding;
and (4) Implementing the Commercialization Strategy - coordinate and monitor
the NASA-Industrial-Medical Team implementation of the commercialization
strategy.
Commercialization - The application of NASA technology may result in
a marketable product. A commercialization occurs when this product, or a
variation that also contains the NASA-developed technology, is announced
and/or made commercially available to the public.
Commercialization Opportunity - The efforts of the Team have led to the
identification of NASA technology which solves a significant medical need.
This technological solution is carefully screened. A commercialization
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opportunity is a solution that has been identified by the screening process
to have a high probability of being commercialized.
Computer Information Search - A computerized information search is a
search of the aerospace information bank established by NASA and made
available through six Industrial Applications Centers (IAC) in the United
States. This information bank consists of more than one million documents
that have been indexed and abstracted in the Scientific and Technical
Aerospace Reports (STAR) and the International Aerospace Abstracts (IAA).
Impact - An impact is reported when information is given to a problem
originator with the result that he changes his activities in a way that
enhances his progress toward a medical objective. Thus, an impact is
analogous to a technology application except that some requirements for a
technology application are not satisfied.
Need - A need is a specific and definable technological requirement that
cannot be satisfied by commercially available equipment or by application
of information.that is available to the problem originator through routinely
used problem-solving channels (e.g., hire a bioengineer).
Participating Institution - A medically oriented educational institution,
hospital, medical center, or government agency having as one of its organiza-
tional objectives the improvement of medical health care is listed as a
participating institution. . . if an interactive relationship with a Team
is established.
Potential Commercialization - When the efforts of the Team have led
to the organization of a NASA-Industrial-Medical Team to work on a commer-
I
	 cialization opportunity, and to the development and implementation of
the commercialization strategy, including the tentative identification
of funding, the work is said to be at the stage of a potential commercializa-
tion.
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Potential Technology Application - The search for NASA technology
by the Biomedical Applications Team leads to the identification of
relevant technology that offers strong potential for solving the particular
needs. A potential technology application occurs when the Team and the
problem originator agree on the fpplicability of the specific NASA
technology to the particular need and when a reasonable plan for achieving
implementation exists.
Problem Originator or Researcher - A problem originator is an
individual actively involved in an effort to reach a specific objective
in biology or medicine and faced with a specific technological need that
is impeding progress toward achieving that objective.
Problem Statement - A problem statement is a concise, written
statement of a need used for communicating: (1) sufficient details to
allow a computer search to be performed by the information search specialists;
and (2) sufficient information to enable NASA engineers and scientists
to consider possible solutions to the need. This document should not be
confused with a preliminary problem statement which is a one-page brief
description of the need. This document is designed to initiate the
solution search.
RTOP (Research and Technology Objectives and Plans) - The Biomedical
Applications Team has helped organize a NASA-Industrial-Medical Team to
pursue the commercialization of a commercialization opportunity. Development,
funding, and marketing plans have been prepared. An RTOP is a comprehensive
proposal made by a NASA Center to NASA Headquarters for funding to
support this commercialization effort.
Technology Application - The key factor that permits a potential
technology application to become a technology application is implementation.
A technology application occurs when aerospace technology is implemented
-19-
to solve a need different from the one for which the technology was
originally developed.
Widespread Use of Technology - The application of NASA technology
solves a particular medical need. Widespread use of technology occurs
when this solution, or a variation that also contains the NASA-developed
technology, causes a service or a device to become available to a wide
segment of the public.
THE UW-BAT
History
The University of Wisconsin-Madison was awarded its first contract
to operate a NASA Biomedical Applications Team in 1974. This final report
is the third such report to be filed by the UW-BAT, which is now beginning
its fourth full year of operation.
The original proposal to NASA stressed, as one important component,
the importance of transfering technology to the primary level of the health
care delivery system. Primary health care is delivered during the first
or most basic form of encounter between an individual and the health care
system. It is also the most common form, encompassing such activities as
routine office visits, preventive medicine, and emergency medical care.
The health care providers involved are generally found in general or family
practice, pediatrics, and internal medicine. Included, as well, are
dentists, paramedics, and physician extenders of various types--in short,
those who help patients when they first appear with medical needs.
The UW-BAT concept of operation has been specifically oriented to
technological needs in primary health care delivery. As part of this
emphasis, the Team has been particularly active in Areas of emergency care
R
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systems, such as telecommunications. Since the patient plays a greater
role at the primary level, much of our work has been directed at his
needs, in addition to those faced by providers.
Organization
The members of the UW-BAT are drawn from the professional staff of the
Instrumentation Systems Center at the UW-Madison. This Center is a division
of the Engineering Experiment Station of the College of Engineering at
the University. Currently, five biomedical engineers work on the program.
Three of these split their time between BAT wort, and other projects being
carried out within an ISC organization called the Advisory Center for Medical
Technology and Systems. The Team also has ties with the Department of
Family Medicine and Practice, through the department chairman, who acted as
co-principal investigator for the contract.
Operations
The Team acts to carry out the NASA Biomedical Applications Team Program,
discussed above, through extensive personal contact and frequent travel.
Medical problems involving technological needs are identified by visiting
medical facilities, attending professional conferences, and by referral
from other NASA/TU units. These are processed by individual Team members,
who carry out the searching, matching, evaluating, and organizing activities
as required. Team members are also frequently asked to consult with
NASA personnel on matters pertaining to the overall mission of the NASA
Biomedical Applications Program. The Team, itself, also works with
paid consultants to help carry out its own program.
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ACRONYMS
Following is a list of acronyms used frequently in this report.
The numbers in parentheses are the pages of the report on which a further
explanation for each can be found.
ARC	 Ames Research Center
BAT	 Biomedical Applications Team (16)
COSMIC
	
Computer Software Management 6 Information Center
DFRC	 Dryden Flight Research Center
GSFC	 Goddard Space Flight Center
IAC	 Industrial Applications Center (17)
JPL	 Jet Propulsion Lab, California Institute of Technology
JSC	 Johnson Space Center
KSC	 Kennedy Space Center
LaRC	 Langley Research Center
LeRC	 Lewis Research Center
MAT	 Manufacturing Processes Applications Team
MSFC	 Marshall Space Flight Center
RTOP	 Research and Technology Objectives and Plans (18)
TAT	 Technology Applications Team
TU	 Technology Utilization (NASA program and Office) (1)
UW	 University of Wisconsin-Madison (19)
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PROBLEM STATEMENTS
Problem UW-6 - Unobtrusive Bio-
feedback Device for Treatment of
Petit Mal Epilepsy
The Need: An unobtrusive device to continuously monitor the electro-
encephalogram (EEG) of children in their normal environment, process the
signal and provide an audio feedback f e r a particular waveform. Particular
needs are for (1) an electrode system for long-term, continuous application
and which will produce usable EEG signals, and (2) signal processing
circuitry.
Background: Epilepsy is a major health problem affecting an estimated 2
million individuals. Petit mal is a type of epilepsy which typically
affects children between the ages of 2 and 16, and is characterized by
momentary or brief loss of consciousness. There is no apparent perception
or recollection of the blackout by the individual. The duration and
frequency of seizures vary widely and may last from 20 seconds to several
minutes, and occur as frequently as every five minutes. Petit mal is
distinguished from grand mal, the classic convulsive of epilepsy, in
that it generally afflicts children and usually either dissipates or
becomes grand mal near the end of adolescence. While not as traumatic
as other forms of epilepsy, petit mal seizures can result in significant
learning problems for children affected, as well as social stigmatization
and many difficulties. Currently, anti-convulsive drugs are the most
-25- 	 ^	 iKs
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effective way of controlling petit mal epilepsy. The prototypic drugs
for the therapy of petit mal are trimethadione and ethoeuximide. both
drugs have side effects and require close medical supervision, especially
in the first year. The most common side effects from ethosuximide are
gastrointestinal complaints of nausea, vomiting, loss of appetite;
nervous system effects such as drowsiness, dizziness, headaches, lethargy;
etc. All a! the drugs used in petit mal therapy can produce a variety
of undesirable and potentially dangerous side effects. Thus alternatives
to drug therapy, such as the suppression device, would offer potential
advantages to both the doctor and the patient in the treatment of petit mal.
The BATeam had been previously involved in the refinement of a
miniature wearable device for the suppression of acoustiomotor epilepsy
in children. The device detected sudden changes in noise intensity
above the child's background level and produced an aural stimulus which,
after conditicning training, was successful in suppressing reflex seizures.
The Suppressive Device: At the onset of a petit mal seizure, the child's
electroencephalogram (EEG) contains a characteriatic waveform sometimes
referred to as "spike and wave" pattern. A prototype device has been
developed t,) detect this characteristic slow wave activity of the abnormal
EEG and thus determine when a seizure occurs. The EEG is obtained from
electrodes placed behind the Hers and fastened to eyeglass frames. This
is done to make the electrode arr: y as unobtrusive as possible to permit
use of the sensory system continuously in a child's normal environment.
To date silver/silver chloride electrodes have been used, but cap::citantly
coupled electrodes being developed under contract to JSC will be evaluated
as soon as prototypes are available. These sensors. if successful, would
greatly enhance the suppressive system potential use due to simplified
s
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sensor fixation and freedom from site preparation and electrode
cleaning. The electronic module would be of a smell size suitable to be
worn on a belt or in a shirt pocket. A micropower EEG amplifier developed
by Ames Research Center is utilized. The principle of detection of the
abnormal EEG depends on two parameters: (1) the number of slow waves of
a particu::r frequency band within a time inter--:', and (2) the amplitude
of the slow waves, which is typically twice that of normal EEG amplitude.
Eech criteria must be individually tailored to each child for optimum
results. Once the seizure is detected, an auditory signal to which the
patient has been conditioned, is delivered to the child by an earphone.
Preliminary laboratory atudaes have shown that delivery of an alerting
stimulus directly after onset of seizure activity may interrupt propagation
and suppress the seizure. Additional outputs for functions in addition
to therapy could be a signal also sent to the teacher in the classroom
to enable identification of the child's seizure, and an intrinsic or
external recording rtchanism to record the number and frequency of
seizures to both evaluate the therapeutic mode of the audio feedback,
and additionally, the effectiveness of drug therapy.
The prototype device has been evaluated using magnetic tape recordings
from children during petit mal seizures. Additionally, clinical tests
have been conducted on patients at the Neurological and Rehabilitation
Hospital, which is associated with the University of Wisconsin-!Madison.
Functional testing to date, both on patients and with the recorded
tapes, has demonstrated reliable recognition of the slow wave activity
associated with seizure onset, and a high degree of rejection of noise
and other artifacts for the device. False positives were very minimal
after adjustments to the individual's characteristics were done.
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In order to help determine the market potential for the petit mal
suppressive device, a product concept test was undertaken by the Biomedical
Applications Team in conjunction with the Bureau of Business Research
and Service of the Graduate School of Business Administration, University
of Wisconsin-Madison. The concept test consisted of a mail questionnaire
which was sent to a random sample of 400 neurologists throughout the
United States. The questionnaire assessed the physician's opinion of
the merit of the gener a l product idea, the worth of the device as a
therapeutic and diagnostic tool, the physician's reaction to some con-
templated selling prices, and solicited the physician's general comments
regarding development of the described device. The majority of the
neurologists responding to the questionnaire perceived the device, if
clinically validated, as having significant diagnostic and therapeutic
benefits for the petit mal patient. The majority expressed interest i..
recommending the device for use by their patients if it were commercially
available. Subsequently, a market study of the petit mal suppression
device was conducted by the IIT Research Institute in Chicago, Illinois.
This study concluded that there were significant disadvantages to the
chemotherapy presently used to suppress petit mal seizures in children,
and that it was the perception of clinicians that a functionally operable
electronic device would have desirable features if cost factors were not
extreme. The IITRI report estimates that over the next five years, a
clinically validated suppressive device would find uee by more than
37,000 petit mal patients in the United States. They also indicated
that a significant need existed for diagnostic units of more flexibility,
and that approximately 7,000 of these units would be needed over the next
five years. Additionally, the IIT Research Institute estimated there may
be other applications for a device of similar technology for measurement
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of onset of sleep or loss of attention in hazardous occupations such as
truck drivers, railroad personnel, defense applinations, and others.
Current Activity: A petition for waiver of rights to this invention on
behalf of the Wisconsin Alumni Research Foundation (WARF) was filed, as
well as on a patent application. Unfortunately, between the date of appli-
cation and the time of review by the Patent Office, a new patent was
issued on a similar concept. This could not be identified during the pre-
application investigation as it had not been issued. The newly issued
patent covers some of the concepts developed in UW-6, although not employing
artifac t_ rejection circuitry to reduce false detections. The existence of
this similar patent, however, increases the likelihood of an interference
and attendant litigation. These factors reduce the attractiveness of early
involvement by commercial interests in the device product concepts. Conse-
quently, the request for waiver of rights has been withheld and this project
has been moved to holding status with respect to BAT priority.
Research is continuing by two medical investigators, however, to further
explore the utility of the concept and gather more data to determine if
further development is warranted. Dr. Ruggero Fariello of the Neurological
and Rehabilitation Hospital will use the monitoring device on selected petit
mal patients. A •'ditionally, in a separate research program at the University
of Arizona Medical Center, funding has been secured to replicate the petit
mal monitoring device. Dr. Philip Walson will conduct this investigation,
a collaborative effort between the departments of Pediatrics and Pharmacology
to assess drug effects in children with petit mal disease.
Problem Investiga tor: Dr. Charles S. Cleeland, UW Department of Neurology.
BATeam Coordinator: James C. Houge.
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Problem UW-10 - Coating for Chronically
Implanted Devices Impermeable to Water
Vapor
Help Wanted: Commercialization sources.
The Need: An easily applied coating, impermeable to water vapor for
plastic encapsulated implanted electronic devices.
Background: Nearly all electronic assemblies presently used for chronic
implant, notably cardiac pacemakers, are encapsulated in epoxy resin with
an overcoating of silicon rubber. While this is a biocompatible
packaging configuration, both the silicon and the epoxy have relatively
high rates of water vapor permeation. After a somewhat viable time
period, this results in the electronic circuit operating in a 100% relative
humidity environment. Any contaminants on the electronic assembly left
during the fabrication, if containing any ionic material, will result in
corrosion, shunting of the electronic circuit, and erratic operation or
failure of the assembly. Some newer designs are totally encased in a
metal or ceramic case which is hermetically sealed to circumvent this
water vapor permeation problem. This, however, is a relatively expensive
and exacting process which adds to the cost of the device. If a glass
or metal coating which would be impermeable to the water vapor could be
applied to a plastic encapsulated electronic assembly, it might be possible
to achieve the same degree of protection to the circuitry at a reduced
cost and simplified processing of the assembly.
Present Status: A specific application problem for environmental sealing
was posed by Professor Paul Bass of the Department of Pharmacy and
Pharmacology at the University of Wisconsin. Professor Bass is developing
instrumentation to measure rate of flow from the stomach into the small
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intestine of dogs. He is attempting to use a thereto-anemometry technique
utilizing glass microbead thermistors attached to a microminiature
teflon-jacketed cable. Environmentally protecting the thermistors and
associated electrical connections in a thin and highly conforming durable
coating has been very difficult to date using commercially available
conformable coating materials. The intended result of this investigation
would be a clinizally usable device to assess stomach emptying in humans.
Contact was made with Dr. Ted Wydeven at NASA Ames Reaearch Center, and
an agreement was reached to coat samples using this plasma coating process
developed at Ames for halide lenses for evaluation by the UW-BAT.
The evaluation program was proposed as an adjunct to the ongoing Ames
RTOP which has not yet begun, as this program has not yet been funded.
In the interim, samples will be coated by Dr. Wydeven and tests conducted
by the UW-BAT to quantify the water vapor permeation rate. The level of this
parameter will indicate whether promise exists for an implanted vapor barrier.
Successful evaluation would likely result in commercial interest by several
manufacturers, including Ohio Medical Products, who has contacted the BAT in
search of such a coating.
Problem Investigator: Dr. Paul Bass, UW Department of Pharmacy and Pharmacology.
BATeam Coordinator: James C. Houge.
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Problem UW-15 - Wide Area
Medical Cow unications
Help Wanted: Commercialization possibilities.
Abstract: The provision of physician background is important in the
optimization of on-site emergency care but is difficult to provide outside
urban areas. Needed is a method for providing reliable automatically con-
trolled medical communications between an emergency medical technician and
a hospital beyond direct radio range.
Background: One of the mist significant aspects of quality emergency
medical service (EMS) is the provision of on-site emergency medical
assistance by trained emergency medical technicians (EMTs). An important
element in maximizizr- EMT effectiveness is the availability of physician
advice during pre-hospitalization care of the emergency patient. However,
the advice must be directly and reliably available on a 24-hour basis.
Unfortunately, outside of urban areas, hospitals are generally unable to
staff emergency rooms with physicians on a 24-hour basis. This need for
physician backup is particularly crucial in EMS systems utilizing volunteer
EMTs who see duty infrequently and find it difficult to maintain a high
level of experience and proficiency.
Many states have existing statewide microwave systems which could
probably be used for EMS on a shared basis. EMTs statewide could then
gain access over the microwave system to medical backup. In most such
potentially shared systems, the dispatchers and controllers have primary
responsibilities other than in EMS. Moreover, channels reserved for
medical communications require a high degree of reliability even though
they might be infrequently used. Thus, in order to be practical, shared
r
t
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use of a system must be automatically controlled and channel usability
continuously monitored. It would appear possible that by means of
automatic channel control and monitoring equipment, an EMS vehicle would
be able to communicate directly over a shared microwave network with a
physician at a major medical facility having 24-hour, in-house physician
coverage.
There presently exists in Wisconsin a statewide, high band VHF
communications system for EMS which utilizes transceivers on 22 microwave
towers providing coverage for over 95% of the area of the state. With
this system, an ambulance can contact a dispatcher at one of seven area
state patrol headquarters. However, the system as presently configured
does not provide for medical communications. A communications channel
monitor designed under contract to Kennedy Space Center (NASA Tech Brief
61-10028, entitled "Monitor Assures Availability and Quality of Communi-
cation Channels") has been identified as applicable to the solution of this
problem. Moreover, it appears that slight modification of this circuitry
would not only allow channel monitoring, but also provide the required
control function to selectively bypass the state patrol dispatcher and
allow communications directly with hospital personnel.
Progress to Date: One of the 22 state patrol microwave towers has been
selected as a site for tests of a prototype system using this NASA-
developed system concept. The selected tower site is located near
Baraboo, Wisconsin. The Marquette County EMS system has expressed a
particular interest to participate in operational tests of the prototype
system, in view of their present inability to obtain 24-hour physician
backup. Preliminary radio coverage tests have indicated that the entire
Marquette County area is within radio range of the Baraboo tower. University
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Hospitals, Madison, Wisconsin, will provide the medical backup. Design of
the prototype system has been completed. Necessary system components
have been obtained and assembled. It was possible to assemble the moni -
toring equipment required at the hospital terminal on circuit boards which
could fit into a commercially available communications console (see Fig. 1).
I
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Figure 1. Motorola communications console.
w
Implementation was initially hampered by incomplete documentation of
the existing microwave system. Some fears were also expressed by the
hospital administration as to imposing additional pieces of hardware upon
medical personnel without adequate human factors engineering of their
total communications system. The problem is complicated by the fact that
the local paramedical communications system has been recently redesigued.
Operational testing of the system has been additionally del,:-yed as a resuie
of a reliability problem discovered in the sta-e EMS network. State radio
personnel are currently analyzing the microwave control network which has
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been found to be intermittent in operation. This problem has probably
been present since the initial installation of the system over two years
ago, but was not discovered until testing of the NASA channel quality monitor
was undertaken. It was anticipation of this type of problem with low usage
channels on shared communications systems that indicated a need to auto-
matically and continuously monitor channel patency. While the UW-BAT role
in this test program has been essentially completed, completion of the
operational testing has been delayed pending resolution of the problem
discovered in the basic microwave control system.
In spite of the delay in the start of testing of the prototype system,
a great deal of interest has been expressed by health planners from around
the state. Proposals for development of wide-area medical communications
based upon the NASA-sponsored prototype system have been included in three
regional health planning grant applications for implementation funding under
Section 1203 of Public Law 93-154 (Emergency Medical Services Act of 1973).
These applications cover 31 of the 72 counties in Wisconsin. In addition,
the state level 1203 grant application included funding to develop a design
and draft specifications for a statewide wide-area medical communications
system based upon the results of the prototype evaluation.
External Program Contributions: The Wisconsin Division of Health has
committed staff time and mobile equipment to the program. The use of the
state microwave network has been authorized. Additionally, the Marquette
County Emergency Medical Services system will participate in the opera-
tional tests. University Hospitals in Madison will fill the role of providing
24-hour-per-day physician backup.
-36-
Commercialization Potential: Other channel quality monitoring devices
are commercially available and in general use for telegraph and digital
data circuits. However, they are not designed to monitor channels carrying
voice or other signals that contain many random frequencies. Also, they
cannot monitor all the critical parameters of voice and high-speed data
circuits. The communications channel quality monitor developed under
NASA sponsorship has both voice and high-speed data capabilities.
Assuming successful demonstration of the prototype system, it is
anticipated that functional specifications for a monitoring and control
module will become a part of the system proposed for implementation under
the recently submitted grant applications. Following regional application,
the same system requirement would be included in statewide planning.
Replication of the monitoring and control module requirement in other
regions would likely occur.
Several states have in service or are planning the use of microwave
systems for-EMS on a shared basis. Moreover, numerous law enforcement
agencies utilize communication channels in a parallel manner to this EMS
usage. Commercialization potential is enhanced by the possible inclusion
of channel quality monitoring requirements in the specifications for new
public service communication channels.
Problem Investigator: John L. Hankes, EMS Planning Analyst, State of
Wisconsin, Division of Health Policy and Planning.
BATeam Coordinator: Everis R. Engstrom.
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Problem UW-23 - Conformable and
Autoclavable Return Electrode
for Electrosurgery
Help Vented: Commercialization sources.
The Need: A conformable return electrode to make reliable and safe
contact over a large skin area. This would eliminate the possibility of
exit burns and ensure more consistent electrosurgical procedures.
Background: Electrosurgical dispersive return electrodes are normally
supplied in the form of flat stainless steel plates. This configuration
is convenient to place, easily cleaned and steam sterilized. When used
for human electrosurgery, deformation of the buttock normally permits
sufficient contact area to minimize heating due to current passage.
Flexible foil, pre-gelled, disposable return electrodes are available,
which may be wrapped around a limb to establish low resistance contact.
These electrodes are significantly more expensive than the reuse of a
permanent autoclave sterilizable return electrode.
Another aspect of the return electrode problem is that of research
involving small animals such as rats and small dogs. The sharp body
contours of these animals make establishment of a low resistance, large
area body contact for RF current very difficult. A conforming return
electrode would have potential benefit for both human surgery and for
animal research.
Present Status: Return electrodes capable of withstanding repeated
autoclave sterilization and flexible enough to closely conform to body
contours were fabricated from high temperature silicone elastomers,
filled with conductive particles. Materials and suggestions were provided
fJ.^. I.I. I.^.i	 1. ^...^ ^ 	 1•.
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by Dr. Salvador Rositano of Ames Research Center. Materials included
^ i licone rubber filled with carbon, silver flake, and silver plated
',lass microspheres. The electrode sheets were approximately 10 cm x
10 cm and 2 mm thick (see Figure 1). Comparative evaluations were
performed between the conductive elastomeric return and a stainless
steel plate electrode after five steam sterilization cycles. Both cut
and coagulate modes were conducted using both organ (pork liver) and
muscle (rat) tissue.
W-
Figure 1.
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A solid state electrosurgical generator was utilised, and the active
electrode for all procedures was a 2 mm x 15 mm blade. No significant
difference was discernible for either cut or coagulation in power required
to achieve satisfactory technic with several investigators executing both
procedures. Clean cuts and comparable rates of coagulation were demonstrated
at similar power levels for both return electrode types.
An invention disclosure has been filed on this electrode design and
transmitted to NASA Headquarters. Contact has been made with two companies
who have expressed potential interest in development and marketing of a product
utilizing conductive elastomeric material. Both Cameron-Miller of Chicago
and In Vivo Metric Systems of Redwood City, California have indicated that
further test data and a more detailed cost analysis will be necessary to
their decisions about participation in commercialization of the concept.
Tests of comparative tissue interface impedance with various configurations
will be conducted first quarter of CY 1978. Two vendors capable of compression
molding the conductive elastomer have been contacted and will provide price
quotations on fabrication costs for the electrodes to complete the
information package.
Prob lem Investigator: Charles E. Yale, UW Department of Surgery.
BATeam Coordinator: James C. Houge.
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Problem UW-24 - Automated Patient
Tracking System
Help Wanted: Identify applicable NASA technology.
The Need: A hardware/software system is needed to gather data on the
flow of patients through an ambulatory care clinic and other restricted
settings.
Background: That health care is growing increasingly complex, costly,
and in many cases inefficient, is an oft-repeated truism in America
today. One solution to the problem lies in the application of new or
improved management techniques to the medical clinic. Whenever a system
is changed, however, it is prudent to have available an objective means
Zo evaluate the system before and after the change.
In the case of a medical care system, virtually all studies undertaken
for analytical, planning, or evaluation purposes depend upon manual
methods of data acquisition. These are largely of two types: forms,
including the medical records in normal use, and observations made by
trained observers. In both of these, human factors can severely restrict
the completeness, accuracy, availability, and continuity of the data
being acquired.
Specific Focus: The investigator has taken part in discussions leading to
a project in which JPL conducted analytical and modeling tasks for the
UW Department of Family Medicine and Practice. The overall purpose of
the project was to improve patient care being delivered in family practice
clinics by optimally configuring space and procedures in the clinic. It
is believed that the management control being sought can also b_^ applied
to other primary care facilities.
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An important aspect of the concept, both in terms of validation of
the model as well as the general applicability of the results, is the
need for data describing patient flow. Present plans call for the
acquisition of these data using one or both of the manual techniques
described above. The use of automated data acquisition caethods, however,
appears to be feasible and offers many advantages. Amoug these would be
accuracy, continuity, and greatly decreased interference with ongoing
medical activities.
BATeam Activity: The need is for a system to track and document the
passage of patients through a primary care facility. Two major impedi-
ments to the implementation of an APT system are (1) more precise informa-
tion on what data are needed and how the results would be used, and (2) funds
to set up a prototy pe system. We are investigating NASA sensor technology,
computer software, display equipment, etc., but there is no provision,
at the present time, of adequate funds to design, build, and test a
prototype APT system.
The design concept would be to place either sensors or special
reading devices at locations throughout the clinic. The former would
operate entirely without human assistance while the latter would require
the patient to feed an ID card of some sort into the readers sequentially
as he passed through the clinic. A minicomputer would receive signals
from the sensors/readers on-line, store the event and provide for
management interaction at any time.
Progress Summary: A biomedical engineering student at UW-Madison has carried
out a small-scale investigation of problems associated with gathering data
on patient flow in an ambulatory clinic. His data acquisition system
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required the manual entry of times and events on computer cards which
were subsequently optically read into a computer. He found that c:inic
employees accustomed to routine, such as the receptionist, coulu provide
sufficiently accurate data after a short practice periou, but health
care providers, such as nurses and physicians, either would not or could
not comply with the data acquisition requirements. Thus, patient flow data
could not easily be obtained for much of the course of the visit. The pace
and dynamic character ^.lf --he patient/provider encounter, coupled with the
priority of delivering heal^h care over efficient management, made the
data acquisition system relatively useless. This result confirmed the
hypothesis that the acquisition of patient flow information must be automated
to be effective.
Furt ►:er study of the needs of such a system is needed so that specific
requirements can be stated. The need appears to be very broad since most
health care, measured in terms of patient encounters, occurs at the primary,
or first contact, level of care. Besides general applicability in the
health care system, a data acquisition system that monitors the whereabouts
of people in other restricted settings, such as nursing homes, migh^ yield
savings and increase effectiveness.
Since the Team is committed to finding ways to transfer NASA technology
to the service of primary care needs, further work on this problem statement
is anticipated. Our attention to the problems of the aged also suggests the
need for continued attention to the subject of this problem statement.
Problem Investigator: Dr. John H. Renner, Dept. of Family Medicine and
Practice, University of Wisconsin-Madison.
BATeam Coordinator: William N. Fetzner.
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Problem UW-30 - Multi-Spectral
Analysis of Tissue Viability
Abstract: There exists a need for a surgeon to noninvasively determine
the optimum leve l -of amputation on patients with drastically impaired
circulation of the limbs. The Jet Propulsion Laboratory has modified a
NASA computer-enhanced optical process and is presently using it to aid
physicians in the diagnosis of burn patients. This technique may have
applicability to the amputation problem.
The Need: According to Dr. James S. Keene, Assistant Professor, Division
of Orthopedics (under joint appointment with Lhe VA and University of
Wisconsin hospitals, Madison), the specific level of amputation chosen in
patients with ischemic changes is generally based upon the judgment and
experience of the surgeon. Dr. Keene believes presently available objective
criteria such as level of distal pulse, skin temperature and angiographic
patterns of disease have not proven to be reliable predictors of eventual
amputation healing, and that a system capable of quantifying skin and muscle
blood flow could better predict successful levels of amputation.
Background: Dr. Victor Anselmo of the Jet Propulsion Laboratory has been
primarily responsible for the development of the computerized burn analysis
system presently in use at the University of Southern California Medical
Center. Two systems have been developed, one employing conventional 35 mm
photographic techniques, and the other using a specially designed scanning
camera head. The photographic; system, as originally configured, operates
as follows.
Three conventional 3.) mm SLR cameras simultaneously photograph
the burn area through three optical filters: near infrared (Kodak 89A),
yellow-green Oloya "X-1"), and red (Hoye 25A). The films employed are
!	
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high speed infrared, and "plus X," both commercially available black and
white films. Two additional cameras are used without filters to photograph
the burn area, both in black and white and in color. These latter
photographs are used for comparison and reference only. The photographs
are taken in a darkened room using an inexpensive Xenon strobe light.
The black and white photographs taken through the three filters are then
scanned by a high resolution optical system at JPL, and each point on
the photograph is assigned a number (quantitized) on a gray scale.
These digital values are fed into a computer. The computer software
registers the photographs to correct for parallax, and then computes
three ratios for each point: red to yellow-green, infrared to yellow-
green, and infrared to red. The ultimate output is a color-coded print
of the burn area that shows partial-thickness burns as blue regions,
partial-to-full-thickness burns as red, and full-thickness burns as
yellow-green.
The system presently undergoing clinical trials at the USC burn
ward utilizes a camera head with a planar scanning mirror to sequentially
optically transmit the burn image to three filters backed by linear
photo-diode arrays. The information is digitized, processed by a mini-
computer and ultimately appears on a color TV monitor. The display format
is similar to the pseudo-color picture obtained using the previously described
photographic system.
The multispectral analysis technique employed by these two systems
essentially maps the hemoglobin oxygenation of subcutaneous vascularization
to a depth of 3 to 4 mm. It vividly contrasts zones of hyperemia, stasis,
and coagulation, and should enable the surgeon to determine at an early
stage those areas that will require skin grafts in order to heal.
J
r
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Progress - Application to Peripheral Vascular Disease Diagnosis: To determine
the applicability of the multi-spectral analysis techniques to peripheral
vascular disease diagnosis, two patients with peripheral vascular disease
were photographed at the VA Hospital in Madison by Dr. Anselmo of JPL. The
photograr*.s were taken through a series of optical filters both prior to,
and following, application of radiant heat to the affected limbs (dilation
of the surface vasculature due to increased skin temperature accentuates the
effect of any vascular flow restrictions). Pressure profile recordings of the
affected limbs were also taken under the same conditions using an occlusive
cuff (non-invasive) measurement system. Brief medical histories of the
two patients are as follows:
(1) Patient A suffers from bilateral leg pain after walking several
minutes, has a history of hypertension, and due to poor
circulation has undergone amputation of the left great toe.
Pressure recordings and arteriography suggest local inflow
obstruction of left iliac system.
(2) Patient B, a diabetic, was recovering from burns on the calf
of one leg. The burn had been incurred by overexposure to
the radiant heat from a wood-burning stove, and had been
aggravated by prior frostbite of the area.
The photographs taken at the VA Hospital were analyzed at JPL, and the
results conveyed to Dr. Turnipseed at that hospital. There were pronounced
differences in the spectral reflectance characteristics between the diseased
and more normal areas of tissue for both patients. While it was not possible
to determine the optimum filter types for most effective differentiation due
to the limited data, both Dr. Anaelmo and Dr. Turnipseed were encouraged by
the findings and felt that further controlled studies of patients with
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peripheral vascular disease using the JPL/NASA processing technique were
warranted.
Progress to Date: A meeting has been scheduled with Dr. Turnipseed at the
VA Hospital for mid-January 1978 to discuss specific methods of applying
the JPL/NASA multispectral analysis techniques in studying several patients
with peripheral vascular disease. An evaluation of this technique will be
coordinated with other approaches proposed by the VA Hospital in Madison for
vascular disease diagnosis.
Problem Investigators: Dr. James J. Keene, Dr. William Turnipseed, and
Dr. Theodore Goodfriend, VA Hospital, Madison, Wisconsin.
BATeam Coordinator: L. Burke O'Neal.
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Problem UW-32 - New Femoral Head
Prosthesis Design to Improve
Long-Term Stability
Help Wanted: Identify interested companies.
Abstract: Femoral head prosthesis failure has proven to be a clinically
significant problem. Host rejection of cement, loosening through bone
resorption cnd fatigue failure of the stem due to loosening are major
modalities of failure. A new design has been proposed to solve these
problems, but needs further investigation.
The Need: "Today we are still living in the revolutionary era of total
hip replacement, a worldwide revolution in which about 20,000 orthopaedic
surgeons are more or less involved and nearly 1 million patients are
personally involved. There is such enthusiasm that now some surgeons
are performing total hip replacements in patients under 50 years of
age." 1 A recent market study shows that just the West European market
for implant devices for long-term use was $280 million in 1975, projected
to increase to $430 million by 1980. 2 In spite of the vast number of
total hip replacement procedures performed around the world, pioneers in
the field such as Maurice E. Muller and John Charnley acknowledge the
fact that late complications and failures of the femoral head component
are clinically significant. Patterson and Brown  have reported an
incidence of 31% major complications in the first two years after total
hip replacement. Total hip procedure became popular in the United
States only after 1965, as opposed to 1958 in Europe. The recent statistics
from Europe indicate that today there are as many procedures redone in
Europe as there are new cases.
One mode of failure is fracture of the stem. In all cases of such
fracture, loosening of the proximal half of the stem is observed.l
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Another cause for loosening may be allergy or host rejection of
methylmethacrylate cement (0.5% of cases), used to bond the prosthesis
to bone. This takes place within 1 year following the operation.
The main complication, however, is loosening after 5 years. To
understand the loosening problem, we have to know that no real bond can
occur between bone and cement. A fine layer of fibrous tissue always
will develop between cement and bone, thus permitting some movement
between the elastic bone and the rigid cement. If the medullary cavity
is not fully packed or if the bending forces are too great, for example,
in a prosthesis fixed in a varus position, the movement at the interface
between cement and bone will soon increase. This will lead to bone
resorption, fibrous tissue formation, and gradual loosening of the
femoral stem in the first years following a total hip replacement.l
Specifications: A new design of a femoral head prosthesis has been
proposed which would offer improved long-term stability.
Actions Taken:
Patent Status of the New Design: The femoral head prosthesis design
was reported to the contract monitor, Mr. Don Friedman, under the "New
Technology" clause of the contract. Subsequently, a decision was made by
the Wisconsin Alumni Research Foundation (WARF), a non-profit patent
management organization that represents the University of Wisconsin :n
patent matters, to file for a waiver of rights to the invention. The
premise for the waiver application was that WARF and the University of
Wisconsin then would practice and commercialize the invention using their
own resources. Through a letter dated October 25, 1977, the Board of Regents
of the University of Wisconsin System were informed that the NASA Inventions
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and Contribution Board had recommended to the Administrator that the
petition be granted (Waiver No. W-1876). Notification of action by the
Administrator on the waiver has not been received as of this date.
NASA Technology: Substantially relevant NASA technology was located
at the Ion Be m Applications Section, Space Propulsion 6 Power Division of
Lewis Resear Center (BAT quarterly report July-Sept. 1977). It appears
that the ion eam technology could be used to fabricate the porous polymer
sheath which is the unique feature of the proposed design. A January meeting
has been pla ned with Mr. Bruce Banks, Head of Ion Beam Applications Center
and Paul fos er, TU officer at Lewis, to discuss feasibility of this tech-
nology appl cation.
Commercialization Plans: After the waiver notification is received, an
invention a0plication will be filed by WARY. Companies in the orthopaedic
implant bus4less will be contacted according to commercialization strategy
,jointly dev Iloped with WARF.
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Problem UW-33 - Miniaturized Force
Transducer for Gastrointestinal
Motility Studies
Help Wanted: Size of market, possibility of developing standard configura-
tion, identify custom manufacturer.
Abstract: Needed is an implanted, miniaturized force transducer suitable
for monitoring the force of contraction of individual contractile segments
of the small bowel of unanesthetized animals for periods of at least six
months. Various transducers which may be applicable have been developed
by NASA and are being investigated for possible application.
The Need: Several patterns of gastrointestinal tract smooth muscle con-
tractile activity, referred to as motility, have been described. Specific
patterns of motility have been associated with pathologic states such as
diarrhea and constipation. Because intraluminal devices and anesthetics
can markedly affect motility, extraluminal force transducers which may
be used to monitor contractile activity in the gastrointestinal tract of
unanesthetized animals have been developed. Currently used transducers
are approximately 1.5 cm long, 0.7 cm wide, and .3 cm thick. In the
small bowel of the dog, the length of an individual contractile segment
is approximately 1 cm. In order to define the pressure-flow relationship
in the intestinal lumen, it is necessary to determine the contractile
profile within an individual contractile segment. What is needed is a	 4
miniature force transducer which will allow determination of the contractile
profile of an individual, 1 cm long contractile segment.
Specifications: The width is the critical parameter. Ideally, s width
of 1 mm or less is desired. The length should be 1 r!m or less. Forces
to be measured are 0-100 g.
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Actions Taken: A computerized search of the NASA data base has been
completed. Known relevant NASA technology is being evaluated for possible
application. A NASA-patented miniature catheter tip force transducer
(Patent 3,971,364) developed at JPL may be modifiable for this use. The
possibility of obtaining some prototypes from JPL for evaluation by the
problem originator is being investigated. Also, an attempt is being made
to determine if a significant number of other researchers would be interested
in strain gages of this configuration. If that proves to be the case.
commercialization efforts may be worth pursuing.
Problem Originator: James Christensen, M.D., Director, Division of
Gastroenterology, University of Iowa.
BATeam Coordinator: Everis R. Engstrom.
-52-
Problem UW-34 - System to Provide
Quantifiable Vestibular Stimulation
and Motor Response in Children with
Delayed Development
Help Wanted: Methods for vestibular assessment for children.
Abstract: The methods used presently for clinical evaluation of develop-
mentally delayed children and for the provision of vestibular stimulation
for therapy are predominantly manual, quite subjective, and result in con-
siderable scatter. The development of means for quantifying both the
input vestibular stimulation and more exact measurement of motor per-
formance would be of significant value in the clinical setting.
The Need: Some children experience developmental delay as a result of
sensory deprivation caused by slow maturation, coupled with inadequate
responses of the sensory and motor systems to environmental stimuli.
Therapeutic intervention to counteract these delays normally take the
form of sensory enrichment programs. Physical and occupational thera-
pists working with developmentally delayed children use developmental
behavior patterns including specific postures that involve the child's
nervous system in stimulus, integration and response. An operational
hypothesis is that a specific vestibular (occurring in the semicircular
canals of the inner ear) stimulus applied over a specified period of
time will effect an improvement in motor performance. The parameter
most often used as a measurement of vestibular response is the degree
and interval to acquire nystagmus (an oscillatory eye movement) habitua-
tion due to vestibular stimulus.
Specifications: Stimulus to the vestibular apparatus is most often
achieved by rotating the child either manually or on a rotating platform.
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Variation of the inclination of the specific pairs of semicircular
canals, combined with differing angular velocities, accelerations, and
decelerations, are used to provide varying input stimulus. Probable
speed range required would be in the order C 20-44 rpm, with capability
of up to two feet off-center displacement would initially be desirable,
with the capability of fixation of varying degrees of angulation of the
child's head to provide varying stimulation. Ideally, the capability
for speed variation or other means to provide elliptical movement or
multiple cycles of acceleration/deceleration per revolution might be
clinically useful. The capability of self-control and braking to
terminate unpleasant experience by the child would also be desirable for
older children. Instrumentation to record the EOG and EEG might provide
more quantitative measures of motor performance than visual observation
of subject eye movement during rotation.
Actions Taken: A literature search has been initiated to identify work
done by NASA including measurement of astronaut response to acceleration
and deceleration and centrifuge setting to identify potentially applicable
NASA technology and/or methodology. Information on vestibular assessment
programs for both the Apollo crew and in-flight tests done on Skylab have
been given to Professor Punwar for review.
The Rotating Litter Chgir developed at Johnson Space Center and used in
Experiment M131 on Skylab incorporates all of the necessary features for a
system for vestibular assessment of children. It is probable that a device
intended for therapy could be a simplified version of the litter chair.
Collaborative support for the initial phase of specification development
and functional definition has been obtained from non-NASA sources. A
protot y pe device was fabricated and will begin evaluation in January
1418. Results of these tests should provide the basis for better functional
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definition of required system parameters and permit development of a
product concept and commercialization plan.
References:s
1. "Environmental Modification of Autistic Behavior," Ornitz, A.
Arch. Gen. Psychist. :22, 560-565, 1970.
2. "A Disorder of Sensory Motor Integration," Infantile_ Autism Concepts,
Characterization, and Treatments, pp. 50-68, London, 1971.
3. "Effects of Vestibular Stimulation on Nystagmus Response and Motor
Performance in the Developmentally Delayed Infant," Kantner, R., et. al.
Physical Therapy, 56:4, 414-421, April 1976.
Problem Originator: Alice Punwar, Director, Occupational Therapy Program,
UW-Madison.
BATeam Coordinator: James C. Houge.
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Problem UW-35 - Portable Dental
Equipment
Abstract: A need for portable, modular, dental equipment has been identified
by the UW-BAT to deliver dental care in rural areas here and abroad, and to
provide such care to armed forces personnel on active duty, handicapped
children, chronically ill adults and prisoners. A similar need exists in
public dental health programs to conduct preventive dental care clinics for
the underprivileged youth population. There seems to be a potential for
transfers from different areas of NASA technology and expertise.
The Need: Traditionally dentists have been confined to their offices and
bulky fixed equipment. There is no commercially available portable dental
instrumentation system. As a consequence, that fraction of the population
who cannot visit the dentist on a regular basis (due to various reasons which
will be discussed later) just do not have any dental care available to them.
Even here in the United States, the lack of dental care is one of the
most critical health care problems of rural people. l The link between
sound oral health and proper nutrition has gained importance only recently.
Early loss of teeth or infected gums will disable a person to chew, hence,
causing malnutrition even in an area where there is an abundance of good food.
A review of existing literature shows an alarmingly high number of
people in this country alone who do not receive dental care of any
significance. The people lacking dental care can be classified into the
following categories.
Indigents:	 In New York City, an estimated 200 000 children (6-14
years) receive only minimal care such as emergencies and extractions.
Handicapped Children and Chronically Ill Adults: Due to long
neglect and debility through illness, these people have very poor oral
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health status. A DREW study in Kansas City showed that 7,000 people as
being homebound.5
Institutionalized: There are 880,000 persons in mental hospitals,
prisons, and other institutions who get only minimal care.2
Since the inception of the Social Security Act of 1935, dental
divisions of the State Health Departments grew from 13 to 50. The dental
divisions are operated by grants from Social Security. In the past there
have been two approaches in catering to the needs of these people:
(a) Fixed location clinics and bussing of people to these clinics.
(b) Mobile clinics.
Both methods are expensive. Bussing people in communities larger than
40,000 is very laborious. 3
 A mobile clinic currently costs about $60,000.
Thus, a lightweight, portable, easy to set up, modular dental system
with a price tag around $10,000 would use the federal funds efficiently
and provide dental care to more persons for the same dollar value.
One other factor contributing to this lack of dental care has been
una ilability of manpower for such operations. The new Health Manpower
":t of 1976 promises to alleviate this problem. The bill authorizes
capitation grants of $2,050 average per full time dental student for fiscal
year 1978 through 1980. The conditions for award of such grants to dental
schools are that "schools must either increase first year enrollment over
that in 1976-77 by 10% or have an approved plan to train all students prior
to their graduation at least six weeks in ambulatory care settings in areas
remote from main teaching site or in areas in which medically underserved
populations reside."
To gain a better insight into this problem area, the 11W-BAT conducted
a telephone survey by contacting 11 prominent dentists across the country
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and two leading manufacturers of dental equipment for their opinions and
experiences (see list at end of this problem statement).
A breakdown of their opinions is as follows:
(a) All persons contacted agreed that there was a definite and urgent
need to deliver dental care to the kinds of people discussed above.
(b) All agreed that it would be worth our while investigating the
possibility of putting together a miniaturized total dental
system using aerospace technology.
(c) Everyone concurred on their opinions that the past and current
lack of demand for such equipment is due to manpower shortages
and funding deficits.
(d) Nine persons, including the two manufacturers, were of the opinion
that demand for such equipment would grow in the next 5-10 years
through increases in manpower and in financial grants.
(e) Two of the dentists had no opinion as to the future of portable
equipment.
(f) Two other dentists thought there would not be a substantial demand
for portable equipment, but qualified the remarks by saying that
their opinions were based on current trends.
Existing System: Dentists requiring portable equipment presently have to
fabricate their own units. In the past, this has been done by Public Health
dentists serving in Alaska and volunteer dentists delivering health care,
under the sponsorship of over 50 nonprofit organizations, 4 in rural areas
of developing nations. It is estimated that there are several hundred
American dentists who offer such voluntary services during the summer,
exclusive of W.H.O. dental programs. The problem investigator, Dr. Barry
Simmons, from Athens, Georgia, founder of Dental Health International (funded
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by the Agency for International Development), has spent the past 13 surmers
providing basic dental care to the rural poor in developing countries.
Although the required specifications of equipment for use abroad will be
slightly different than for American use, the work already done by Dr. Simmons
in constructing the portable dental equipment and his experience in this
area could be the basis for developing an advanced version.
The description of his equipment made up of commercially available
components is given below:
The entire system is shown as it would be assembled in the field
(Figure 1). For details, refer to the schematic diagram (Figure 2).
Although some of the individual components have been made portable as
per the requirements laid down by individual dentists, the system as a
whole leaves much to be optimised.
The heart of the system is a "dental unit" (4) called "Mission-Air"
made by A-Dec, Oregon, one of the largest manufacturers of dental equipment.
It was made to the specifications recommended by Dr. Simmons. This unit
contains the control valving, pressure gauges, water coolant tank and
assorted plumbing for attaching the various dental handpieces, oral auction,
and a three-way syringe. This unit, weighing 16 KGS in the carrying case,
is being sold by A-Dec at the rate of 3 to 5 per month.
The dental unit is powered by compressed air at 2.8-3.8 KG/CM 2,
delivered by an AC motor or I.C. engine driven compressor (1) depending
on field conditions. There is a holding tank (2) to cool the air down
to reasonable temperatures (150-21 00 and to relieve the compressor from
having to run on a continuous basis. A vortex dryer (3) then dehumidifies
the air before it enters the dental unit.
A lightweight dental chair (5) also made by A-Dec has an adjustable
back support and legs for different reclining positions and heights.
r4t'
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The chair has an approximately 6,000 candle power fiber optics light
source (6) attached to it. The light source requires a 220-volt power
supply (1).
Finally, there is a large folding cabinet (8) with all dental power
tools, surgical equipment, and expendable items.
Specifications: Ideally, the system should be modular and lightweight
for easy transport. The types of vehicles used to transport the equipment
abroad vary from horse and camel backs to jeep-type vehicles and carved
wood boats. Sturdy, well sealed, impact resistance containers are a
must to protect equipment and supplies. Within the United States, modes
of transport are light planes, helicopters, and automobiles. The equipment
must be easy to set up in the field by technicians.
A. A compact and lightweight power source and compressor would make
the existing system much lighter. The dentists need a high speed
(100,000 rpm) and a low speed (30,000 rpm) handpiece with speed
control, cooling water for drills, a three-way air-water syringe
for rinsing, oral auction, and sonic and ultrasonic cleaning tools,
all of which, at the present, are compressed-air driven. However,
t'- se need not be pneumatic if there are alternate ways of powering
the tools.
B. A lightweight (9-13 KGS) dental chair, fully adjustable in height
and reclining angle; should be, in addition, collapsible into a
small volume.
C. An optimized inventory of surgical instruments and supplies should
be packaged into a lightweight (13-18 KGS) supply chest. Currently,
with the supplies, the unit weighs 130-180 KGS.
D. A compact sterilizing chamber (not shown) is required for the
drills and instruments. Possibly, the unit could be built into the
supply chest for a 2-in-1 function.
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E. A dental X-Ray unit including a miniaturized processing lab also is
highly desired by the dentists working in field locations. Locating
the patient and the X-Ray head with no relative motion between the
two is a problem in the field.
Actions Taken: Various NASA-developed technologies were identified through-
out the course of the reporting period which have the potential of making
significant contributions in four of the five problem areas described above.
A. Compressed Air Source. The BATeam contacted Dr. Robert Mallien
from Milwaukee who also has developed compact and portable dental
equipment for use in rural areas. In a joint effort with Dr. Mallien
and a company in New Berlin, Wisconsin, called DOH Composites, a
collapsible compressed air holding tank was developed using NASA and
DOD-developed glass filament winding technology. A flexible resin
developed by D&H Composites allowed the tank to be collapsed to 50%
of original volume when not in service. (For details, see the preceding
three quarterly reports--January-September 1977.) The weight of the
tank is around 10 pounds which is a considerable improvement compared
to the 25-30 pounds of a commercially available steel tank of the
same volume. The composite tank was field tested in Colombia by the
Marquette Medical Dental Team on the international project during the
summer of 1977.
Pin hole type failures prevented the tank from being used
effectively. Efforts are underway to further lighten the weight of
the tank. Mr. Austin D. McHatton, an expert on engineering fabrics at
NASA Langley Research Center, was consulted for possible use of synthetic
fabrics in the tank design. He has proposed a cylindrical tank with
a rubber bladder contained within a fabric sheath. The diameter will
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be chosen to limit the hoop stress well within the yield stress limit
for the fabric and the length of the cylinder will be adjusted for
the given volume. Thus, after use, the tank could be rolled up
much like a fire hose. The Good Year Company has been approached
for the inner bladder design.
B. Dental Chair. A rotating litter chair used during the Skylab mission
to test vestibular function (motion sickness) seems like a :.uitable
design for a lightweight dental chair (see Figure 3). If made from
the composite material support panels and aluminum tubing, the overall
weight can be minimized. Furthermore, the various linkages could be
disassembled into a compact transportation package. Dr. Jerry L.
Homick, Johnson Space Center, is being consulted on the adaptation of
this design for the dental application.
i
Figure 3. Rotating litter chair.
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D. Compact Sterilizer. A commercially available chemical vapor
sterilizer, made by MDT Corporation, E1 Segundo, California, the
Chemiclave 5000 (Figure 4), weighs 18.13 KGS and operates at pressures
in the 1.41-2.82 kg/cm2 range. The BAT, in collaboration with Dr. Mallien
and the MDT Corporation, is trying to develop a modified chemical vapor
sterilizer. The weight reductions can be achieved without sacrificing
structural integrity through the selection of composite materials to
replace metallic components. Mr. Robert Baucom, composite materials
expert at NASA Langley Research Center, has suggested the use of
graphite reinforced poly-imides to construct the sterilizer pressure
vessel. This composite has the capability to retain its original
properties at the temperature (132°C) required in this process. Mr.
Baucom indicated that the first few prototype vessels could be fabricated
at Langley if planned and scheduled through the proper channels. These
activities will be coordinated through Mr. John Samos, TU Officer.
The MDT Corporation has provided a Chemiclave 5000 sterilizer and
all the blueprints necessary to carry out necessary modifications. If
the prototype pressure vessel proves successful, more comprehensive
modifications will be undertaken. Dr. Robert Runnels, Chairman of the
MDT Corporation, has shown great interest in this project. Dr. Runnels
has indicated that if the NASA solutions seem practical, his company
would then be willing to consider co-funding of further development of
the lightweight sterilizer.
E. Portable Dental X-Ray Unit. The most significant NASA technology
contribution perhaps will result in this area. The hand-held dental
fluoroscopy unit, developed at Goddard Space Center, called the LIXI-
scope (Low Intensity X-Ray Imaging Scope), seems to be an ideal remedy
to the problem of field x-ray work. In rural areas, hard-copy x-rays
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	Attractive design enhances	 Convenient aperture permits
	
appearance of any area 	 easy filling of reservoir with
Vapo-Sterd Solution
i
Technical Data:
Overall Dimensions
Chamber Dimensions
Reservoir Capacity
Power Supply
Current
Operating Pressure
Operating Temperature
Weight
Shipping Weight
13" (33 02 cm ) wide x 10 1 : (26 67 cm ► high
x 19 1 : 149 53 cm 1 deep
6' (15 24 cm ) diameter x 11 (27 94 cm) deep
19 fluid O: ( 56 litre)
120V/A C • 60 Hz. 500 Watts
4 2 Amps
20 • 40 psi (1 41 • 2 82 kg/cm')
270 F • 5 (132 C - 2 )
40 pounds (18 18 kg 1
49 pounds (22 27 kg 1
Figure 4. The Chemiclave 5000
are not necessar y
 if a screening capability exists. The RAT will take
a leading role in the commercialization of the LIXIscope. This will
be discussed in a separate section of the report, entitled "Commerciali-
zation Activities."
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Persons Contacted During Telephone Survey:
Dr. Everett Clause, Exec. Director, Christian Dental Society,
Littleton, CO.
Dr. Lloyd Cloud, Asst. Chief for Program Operation, Indian Health
Service, Albuquerque, NM.
Dr. Joseph Doherty, Dental Director, Wisconsin Public Health.
Dr. George Gellespee, Chief of Dental Section, Pan American Health
Organization, Washington, DC.
Dr. Charles Goldstein, University of Southern California School of
Dentistry.
Dr. John Green, Chief Dental Officer, Office of Asst. Sec. for Health,
HEW, Public Health Service, Washington, DC.
Col. Ed Larr, U.S. Army Dental Corps.
Mr. Joe Leiser, Columbus Dental Co.. Columbus, OH.
Dr. McCarten, Chief Dentist, Indian Health Service.
Dr. Charles Meyer, Community Dentistry Dept., Creighton University,
Omaha, NB.
Dr. Tom Pickles, Dental Director, Oregon Public Health.
Dr. Robert Runnels, Chairman, MDT Corp., El Segundo, CA.
Dr. Carlos Saldana, Brooke Army Medical Center, San Antonio, TX.
Mr. Phil Smith, Customer Service Manager, A-Dec, Newberg, OR.
Bibliography
1. Robert L. Nolan, Jerome L. Schwartz, "Rural and Appalachian Health,"
Publisher--Charles C. Thomas, 1973.
2. Wesley O. Young, David F. Sttiffler, "The Dentist, His Practice, and
His Community," W.B. Saunders Co., 1964.
3. James Morse Dunning, "Principles of Dental Public Health," Harvard
University Press, 1962.
4. "Demand Abroad for Dental Personnel and Material Directory of
Programs," Council on International Relations, American Dental
Association, 1972.
5, Tomm H. Pickles, Paper presented at Title V Workshop, Las Vegas,
November 10, 1976.
Problem Investigator: Dr. Barr Simmons, Dental Health International, Athens,
Georgia; and Dr. Robert Mallien, American Red Cross, Milwaukee, Wl.
BATeam Coordinator: Bakki Kudva.
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Problem UW-31 - Primary Care
Education and Response
Help Wanted: Identification of best applications, publisher interest.
Abstract: Training of both intermediate-level health care providers and
of patients to meet primary care needs can be greatly advanced with a
NASA development, the IMSS Checklist.
The Need: Now more so than ever before, a need exists for the clear,
organized, and efficient transfer of information. This is true in all
fields as data and knowledge increases, but it is nowhere more true than
in medicine. Vast sums of money are now spent for health care; the
field is %-onstantly broadening, becoming more complex and growing
increasingly intertwined with other aspects of modern life.
One aspect of the evolution taking place in modern medical practice
is the renewed emphasis upon primary care. Once the most familiar form
of medicine, it had gradually become replaced with specialization and
highly technical approaches to the delivery of health care. The pendulum
has clearly begun to swing back as new forms of primary care are evolving
in this country. Among these are new provider types, who extend the
doctors' capabilities--the Physicians Assistants and Nurse Practitioners--
and a growing reliance upon the patient as an important partner in
medical care.
As the delivery of health care becomes more complex and diversified,
so too does the need grow for better instruments of communication. The
new participants in the health care process, the intermediate-level
extenders and the patients, both need good training aids to develop and
secure their effectiveness.
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NASA Technology: One of the problems faced by physicians charged with
safeguarding the health of astronauts was the problem of health care in
the space-bound capsule. It could not be expected that a physician
would be on board for every mission, so it was clear that astronauts
must be trained and provided with the capability of attending to their
own medical needs.
The solution to this problem for Skylab was to develop a checklist,
to be used with on-board diagnostic and therapeutic materials for medical
purposes. This development, unique to the space program, i;;, known as
the IMSS Checklist. By means of these materials, individuals without
extensive medical training were prepared to meet medical emergencies in
the most effective and expeditious manner. The Checklist has already been
adapted by a NASA field center for application to emergency medical care on
earth, but other applications seem even more promising.
Actions Taken: Plans for the transfer of this technology have progressed
to the point that a BAT-epousored project has been initiated. The purpose
of the project is to (1) investigate in more depth the possible applications
for the NASA checklist, (2) prepare outlines and sample adaptations of the
checklist for the most promising applications, and (3) develop a commercializa-
tion package and strategy for securing the commitment of a publie la ng
company to finish the work and make the results widel y available.
At the outset of the project, the following applications were under
consideration:
1. Training aid for family physicians teaching clinical problem-
solving to medical students and residents.
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2. Training aid for faculty teaching medical decision-making to
physician extender trainees, e.g., Physicians Assistants,
Nurse Practitioners, Pharmacy Practitioners, etc.
3. Reference manual for use by those in #2 (useful in industrial
medicine, remote site practice settings, etc.).
4. Medical guide for hunters, fishermen, backpackers, boaters with
limited or delayed access to physician care.
S. Medical guide for military and public safety personnel required to
give emergency care in remote areas (Coast Guard, state police, etc.).
These plans have been discussed with Dr. Paul Buchanan, Director of
the Biomedical Office at the NASA/Kennedy Space Center, who played a major
role in the development of the NASA Checklist. He has agreed to collaborate
with us on the project. Moreover, he believes that the objectives under
consideration in this project are the early targets for new ways in which
medical care will be delivered in the future. He is interested in such new
tools both for widespread public use as well as to satisfy some upcoming
NASA needs to provide effective, remote medical care.
Problem Investigator: Dr, John F. Renner, Chairman, Dept. of Family Medicine
and Practice, University of Wisconsin-Madison.
BATeam Coordinator: William N. Fettaer.
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Problem UW-39 - Pupillometer--A
Device to Continuously Measure
Pupil Diameter
Help Wanted: NASA technology in solid state detectors and fiber optics.
Abstract: There is a need for an inexpensive device to accurately
measure the pupil diameter in real time. Some Gf the important and
useful applications of such an instrument are in clinical neurologic
diagnosis, monitoring during anesthesia, behavioral screening, pharmaco-
dynamic research, and assessment of narcotic dependency.
The Need: Experimental and clinical studies of the pupil in the fields
of physiology and pharmacology have drawn much attention during the past
century. However, a method of quantitatively measuring pupil response
to various stimuli, named "Pupillography" by the late Dr. Otto Lowenstein,
was introduced only 50 years ago. Ever since, many Pupillographic
methods such as direct measurement using lenses and scales, photographic
methods and infrared scanning methods have been tried.
The constrictor sphincter muscles of the pupil derive their excitory
impulses from the parasympathetic neuro-system. The light-reflex feedback
pathway is included in this system, where impulses originating in the
retina are fed back through a two-nerve relay system to the pupil. The
sympathetic nervous system, on the other hand, innervates the dilator
muscles of the pupil through a variety of pathways. In addition to having
inhibitory effects on the parasympathetic relay system, the sympathetic
pathways can directly act on the dilator muscles through the sympathetic
outflow from the spinal cord at the cervical and thoracic levels. Both
systems are influenced by centers in the upper brain (cortex).1
The involvement of the pupil in these systems makes it an excellent
indicator of lesions and disorders of the system when considered along
ARGYLL AOH6RISON
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with other s ymptoms and a thorough understanding of the complex inter-
connections.
The effects of clinical lesions on pupil response have beers well
documented. Figure t shows pupillograms corresponding to the clinical
lesions most often encountered in practice (for details, see reference 1).
uti !r 
^ I^:1 I.
1"
	
^ IL1	 L R	 ",•_	 I^•l	 1	 R (^	 _	 L R
11." NfAVf	 __	 ^lT( ( !	
_	
^ i TI( TK.Afr
. ^-^'
t Ul NILATCR	 4 81LATCRAL
^l7
4M1.^(Y'ORM
	 ^	 0
'IFfFfNT INIH(1 NfRt'r	 AI)1fS S}'Nf^Rn`^^
Figure 1. Clinical lesions in the paras ympathetic reflex arc.
Y-axis of pupillogram shows pupil diameter in mm and x-axis the time.
The numbers 1-7 indicate the lesions most often encountered in practice.
The corresponding; pupillograms 1-7 show changes in pupillary reactions
caused by these lesions.
Due to the higher brain center links with the pupillar y system, psychotic
disorders, drug addiction, alcoholism, etc., have been shown to cause changes
in the pupil response. Experiments conducted in Viet Nam have shown pupil
diameter to be an excellent differential indicator of heroin intoxication and
withdrawal. Pupil response in Schizophrenics has been documented b y Rubin. 4
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During the induction of anesthesia, the patient may be in an excited
state and his pupils are often dilated. As anesthesia deepens, upper
brain inhibitory influences on the parasympathetic relay system are cut
off, resulting in constricted pupils. But if anesthesia becomes dangerously
deep and begins to encroach upon the mid-brain, the pupils dilate again
and fail to react to light due to inactivation of the light reflex systemsl
This means that monitoring pupil response during surgery could be a valuable
input in controlling the state of anesthesia.
Specifications: In the past, several systems have been described and tried.
Infrared scanning techniques are described by Lowenstein 2 and Troelstra.5
In both cases, the I.R. radiation passes through scanning holes in a rotating
disc or drum and illuminates the eye. Reflected radiation from the eyeball
is collected by a photomultiplier tube, the output of which goes through
the electronics that extract the pupillary diameter from the signal.
Other techniques using infrared film and motion picture photography
have been described by Lowenfeld. 6 Infrared radiation is used in most cases
due to the insensitivity of the retina to it.
The state of the art now is to use silicon vidicons to scan the image
formed by I.R. optics. The vidicon output is fed into computers through a
video-digital interface. Depending on hardware and software capabilities,
the pupil diameter can be calculated in addition to tracking the eye and
focusing the iaage. 7,8 One of these schemes is shown in Figure 2. Devices
that can track the e ye are called Oculometers.
One of the reasons deterring the widespread use of Fupillography as a
common diagnostic tool is its cost. Commercially available systems start at
$10,000 (Applied Science Lab, Waltham, Massachusetts) and go as high as
$100,000 (Honeywell). Thus, it is desirable to have an inexpensive, compact,
^nlv. ra••
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Figure 2. Schematic of the cubic-foot remote oculomuter.
(*These items deleted in cubic-inch version.)
accurate (+0.5X) and linear ( QQ :) pupillometer that can be routinel y used
b y medical personnel without requiring the continuing services (if a technician
or an engineer. Pupillograms as shown in Fignre I can be saved to reflect
the history of pupillar y response.
Actions Taken: A new design for a pupiIlometer was proposed by the RATeam
coordinator. The design is being shown tee several professional persons with
varied backgrounds for a technical evaluation. The design, which involves
A contact lens — fiber optic s y stem was shown to the following persons.
1.	 Dr. J. N. Trainer, Specialist in Solid State Detectors at Goddard
Space Flight tenter.
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2. Dr. Ben Rusy, Professor, Anesthesiology, University of Wisconsin-
Madison Hospitals.
3. Mr. Gene Nutter, Expert in Optics, Instrumentation Systems Center,
University of Wisconsin-Madison.
The design incorporates certain solid state detectors used by NASA in
space. Dr. Trainor has,agreed to provide consultation time at a minimal
level in view of his very heavy mission responsibilities.
At the current time applications for such a device seem to be only in
research studies. Dr. Rusy and other anesthesiologists contacted felt that
such a device would not be necessary to monitor the state of anesthesia in
view of the reliability and predictability of modern anesthetic agents and
also other standard monitoring techniques. However, other applications in
pharmacodynamics and ophthalmology are being considered and appropriate
persons in those fields are being contacted. The market potential of the
design is being evaluated. The design will be reported to Mr. Don Friedman,
Contract Monitor at GSFC as it becomes finalized.
1. Walsh, F. B., Hoyt, W. F., "Clinical Neuro-Ophthalmology," Vol. 1,
34rd Edition, Williams b Wilkins Co., 1969.
2. Lowenstein, Otto, Lowenfeld, Irene, "Electronic Pupillography--A New
Instrument and Some Clinical Applications," A.M.A. Archives of
Ophthalmology, Vol. 59, p. 352, March 1958.
3. Robinson, Malcolm G., et al., "Assessment of Pupil Size During Acute
Heroin Withdrawal in Viet Nam," Neurology, Vol. 24, p. 729-732,
August 1974.
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4. Rubin, L. S., Barry, T. L., "Amplitude of Pupillary Contraction as
a Function of Intensity of Illumination in Schizophrenia."
Biological Psychiatry, Vol. 11, No. 3, p. 267, 1976.
5. Troelatra, A., et al., "A Digital Pupillometer," Medical Research Engr.,
Third Quarter, p. 11, 1966.
6. Lowenfeld, I. E., Rossbrother, H. D., "Infrared Pupil Camera,"
American Journal of Opthalmology, Vol. 78, No. 2, p. 304, August 1974.
7. Merchant, John, et al., "Remote Measurement of Eye Direction Allowing
Subject Motion over one Cubic Foot of Space," IEEE Transactions on
Biomedical Engineering, Vol. BME-21, No. 4, July 1974.
8. Merchant, John, "Fixation Point Measurement by the Occulometer
Technique," Optical Engineering, Vol. 13, No. 4, p. 339, July 1974.
Problem Originators: Mr. Rodney B. Murray and Dr. Ronald J. Tallarida,
Dept. of Pharmacology, Temple University, Philadelphia, Pennsylvania.
BATeam Coordinator: Bakki V. Kudva.
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Problem UW-41 - Design Improvements
for Neonatal Intensive Care Incubators
Help Wanted: NASA technology in aerodynamics and environmental control.
Abstract: There is a need for improvements in infant incubator design
to achieve a stable internal environment unaffected by medical procedures
requiring access to the infant. Aerodynamic techniques might help to
regulate air flow patterns.
The Need: It has been long known that survival rates of premature
infants can be raised by reducing their heat loss. 
1,2 
Heat production
depends largely upon biological oxidation and is a result of the metabolic
activity of all the cells of the body at rest, together with the additional
production due to mcscular activity. When a thermal gradient exists,
metabolic activity rises above basal as much as by 120-140% at 280C
ambient, in a full-term infant as opposed to 0-25% rise in an adult at
the same temperature. 2 An infant lacks the fat and the subcutaneous
tissue layer relative to the adult and in addition has a higher surface
area to body weight ratio. Thus, heat generated in the core of the
infant's body conducts with ease to the surface from which it is then
dissipated at a much higher rate than in adults.
To maximize the chances for survival of a premature or sick infant,
an "optimal environment" has to be created in which the infant not only
has a normal body temperature (32-360C) but also is not stressed
metabolically by a stimulating skin-environment thermal gradient.
Heat gains or losses can be radiant, convective, conductive, and
evaporative. All these factors have to be accurately controlled to keep
the infant's body temperature relatively constant.
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Currently available incubators attempt to prevent these losses by
convectively heating the air within. Humidity levels are maintained
between 50-602 R.H. Though heat loss through evaporation is minimal due
to lack of sweating in premature infants, 2 humidity must be maintained
at sufficiently high levels to prevent irritation of mucous membranes
and to decrease the viscosity of secretions in the pulmonary airways.
The incubator heaters are servo-controlled with temperature feedback
either from the baby's skin or from the return air duct. The temperature
us either controlled by means of a simple ON-OFF operation of the heater
or by a proportional heat control technique where the rate of heating is
proportional to the difference between the desired skin temperature and
its actual value. Behavior of these two systems in time is shown in the
temperature versus time graph in Figure 1.
Environmental temperature variations as large as 5 0C can be seen
and in some cases exceed the skin temperature of the infant (Figure 1-a
and 1-b). In addition, due to air flow patterns and velocity profiles,
there are thermal gradients within the hood itself. Such transitions
can stimulate apneic and bradycardiac spells in sensitive infants. 3,4 A
more desirable environment that is "metabolically soothing" to newborns
is one where the temperature of the air is constrained to 20C below that
of the infant's skin temperature (Figure 1-0.
The problem investigator, Dr. Perlstein, has done extensive work in
this area. To achieve the environment described above, he used a
computer (PDP 11/20) to monitor skin temperature, air temperature,
incubator wall temperatures, heart rate, and respiratory rates of the
infant and control heating and incubator operation. An alg Athm
programmed into the computer is the key to the maintenance of such an
atmosphere. Chance of survival of infants with RDS under computer care
was proven to be significantly higher than those cared for routinely.5
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Figure 1:, Eight-hour summaries of temperature recorded in isolette
incubator chambers heated using three different control
techniques.
In present-day incubators there are some additional problems that
need rectification. When a skin-referenced probe becomes covered by a
sterile towel, a diaper, a flailing arm of the baby or is sandwiched
between the baby and the mattress, the heating of the probe causes the
heater to be turned off exposing the baby to a cold stress. Or when the
thermistor is wet due to milk, urine, or other solutions, it will sense
its own evaporative loss, causing an inappropriate responses 
* From Perlstein, P.H., "Thermal Control" in Iatrogenic Problems in Neonatal
Intensive Care, Report of 69th Ross Conf. on Pediatric
 esearch, p. 75,
Feb. 1976.
I-
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The premature or the sick infant requires more attention and care
than the healthy one. Constant opening of ports for access to the baby,
lifting of the head for procedures like x-ray, blood sampling, catheteriza-
tion, etc., cause the incubator temperature to drop by substantial
amounts (up to 80C) to room temperature. Thermal inertia of the hood
volume, incubator heating circuit and the response time of the thermistor
introduce delays in the reheating-to-equilibrium time. This, unfortunately,
is more harmful to the sick or premature infant than to a healthy full-
term baby.
Specifications: An improved incubator design should incorporate measures
to overcome the shortcomings in the present incubators on the market.
Air flow patterns and temperature profiles within the incubator
hood have not been modeled, measured, or documented. Turbulent zones in
the vicinity of the access ports or turbulence caused by lifting of the
hood or insertion of hands through ports will draw room temperature air
into the hood causing the temperature transitions. The aerodynamics
technology and expertise of NASA should help in modeling and designing
optimal air flow patterns. Air flow within should be designed such that
even with ports open or hood lifted, the baby should be constantly
bathed in conditioned air at a positive pressure.
Temperature measurement techniques in flowing air and relative
humidity sensors would be used in the lesien process. Spacecraft,
spacesuit environmental control systems design technology seems to be
applicable.
To minimize heat loss due to conduction, the mattress could be
designed with a material such as "Temper Foam," which not only would
distribute the baby's weight evenly but also, because of its semi-open
cell structure, permit passage of preconditioned air through it.
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Actions Taken: The BATeam coordinator met with Dr. Dan Bencze, Aeronautical
Engineer of NASA Ames Resarch Center, during a recent visit to Moffett Field.
In the meeting, it was agreed upon that the first step would be to determine
if the problem could be solved using rather straightforward aerodynamic
engineering principles or whether advanced NASA flow and temperature field
computational techniques are necessary. In the former case, NASA involvement
is not warranted. Dr. Bencze has agreed to arrange a one-day workshop at
Ames Research Center to discuss this problem if the problem originator and RED
engineers from any interested companies are willing to travel to Moffett Field.
The BATeam coordinator will attempt to organize the trip in the near future.
Bibliography
1. Silverman, W. A. et al, "Influence of the Thermal Environment Upon
the Survival of Newly Born Premature Infants," Pediatrics, Vol. 22,
p. 876, 1958.
2. Buetow, K. C. et al, "Effect of Maintenance of 'Normal' Skin
Temperature on Survival of Infants of Low Birth Weight," Pediatrics,
Vol. 34, p. 163, 1963.
3. Perlstein, P. H. et al, "Apnea in Premature Infants and Incubator
Air Temperature Changes," New Eng. J. Med., 282, p. 461, 1970.
4. Perlstein, P. H. et al, "An Environmental Trigger to Cardiac Instability
in the Neonate," Amer. Ped. Soc. Meet. Abs., Atlantic City, May 1971.
5. Perlstein, P.H. et al, "Computer-Assisted Newborn Intensive Care,"
Pediatrics, Vol. 57, p. 494, 1976.
6. Edwards, N., "Radiant Warmers," in Iatrogenic Problems in Neonatal
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Problem Originator: Paul H. Perlstein, M.D., Newborn Division of Depart-
meet of Pediatrics, University of Cincinnati, Cincinnati, Ohio.
BATeam Coordinator: Bakki V. Kudva.
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Problem UW-42 - Diagnostic Radiographic
Image Storage System
Help Wanted: Verification of NASA technology; more applicable NASA
technology; commercialization possibilities.
Abstract: Present techniques for storage and retrieval of patient x-ray
films are cumbersome and time-consuming. New techniques are needed to
improve x-ray department efficiency and to reduce the incidence of error
in the filing of patient filmy.
The Need: The vast majority of hospital patients have at least one x-
ray taken during a hospital stay. Many patients have numerous exposures
taken during a series of hospital admissions. The physical volume of
the films which must be stored (for both medical and legal reasons) for
several years is very large. Large hospitals may employ several persons
who do nothing but retrieve past patient films for comparison with a
current radiologic examination. In addition to the problem of providing
convenient storage space for a large volume of "ilms, there is difficulty
in maintaining an accurate film file index. An index is required to
indicate if and when a patient underwent a previous radiographic exami-
nation. Manual index systems are prone to misfiling errors especially
during emergencies and late night examinations. Files may be overlooked
or misplaced and redundant files may be created. Needed is a system for
storage and retrieval of radiographic images which occupies a smaller
physical space and which includes an integrated file index.
Specifications: A significant reduction in present film size would be
desirable. Equipment size may not be critical if remote image input and
display is provided, however. Current commercially available microfilm
-82-
techniques do not in general provide sufficient resolution. The required
resolution is dependent upon the procedure and the x-ray tube focal spot
size. A common tube with a nominal focal spot size of 2 am can typically
resolve a pair of lines 1 am apart. A high resolution .5 mm nominal
focal spot size tube may allow resolution of .25 mm line separation.
Required film format may also change with procedure.
Detailed specifications for an improved system which would be
suitable for the majority of x-ray procedures are being prepared. A
possible system might utilize fluoroscopic and video processing techniques
to directly digitize the x-ray image without the use of expensive film.
Bandwidth compression video coding schemes developed at Goddard Space
Center may be used to reduce the data storage requirements. Gray scale
manipulation may also be desirable prior to data storage. Digitized
images may be magnetically recorded on tape or discs or some other
permanent medium. Digitally stored images would also allow an integrated
patient index system which would reduce errors in record retrieval.
Action Taken: A search for applicable NASA technology is underway. A system
developed for NASA-Marshall by Ampex Corp. (see Figure 1) may be amenable
to modification for this use.
Problem Investigator: Mr. Fred Glab, Radiology Department Manager, Methodist
Hospital, Madison, Wisconsin.
BATesm Coordinator: Everis R. Engstrom.
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Proulem UW-43 - Intracranial Pressure
Display Alarm System
Help Wanted: Evaluate NASA technology; other NASA technology; commer-
cialization possibilities.
Abstract: Intracranial pressure monitoring is becoming a common clinical
practice in neurosurgical intensive care units. Theri is a need for a
system to conveniently display long periods of intracranial pressure
data and to announce clinically important changes with an appropriate alarm.
The Need: Intracranial pressure (ICP) monitoring aids in the proper
administration of drugs and surgical therapy for cerebral edema and in
the diagnosis of various conditions such as head trauma, edema and
recurrent mass lesions, multi-system diseases such as Reye's Syndrome,
and adult onset hydrocephalus. Currently, patients in neurosurgical
intensive care can be rinnitored for ICP for periods up to 30 days pre-
and post-operatively. Typically, the ICP waveforms are recorded on a
paper strip chart recorder. This format is inconvenient for viewing by
nurses and physicians who may be in several different places in a multi-
bed unit and a great deal of paper is accumulated which may contain
unnecessarily recorded information. What is needed is a system which
continuously displays up to three hours cf ICP data on a high resolution
cathode ray tube and which automatically sounds an alarm and makes a
perr"anent recording of ICP upon recognition of particular types of
waveforms. Two types of ICP waveforms are defined in Figure 1. In
addition to these patterns, it would be desirable to automatically
recognize when the ICP quickly exceeds set limits or when the baseline
pressure slowly changes by more than a particular limit.
Systems which perform similar types of display/alarm functions for
electrocardiographic signals are now commercially available. In g3neral,
TI	 i^^^"	 1 ^ 	 '
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DEFINITIONS OF TERMS
Recorded changes in intracranial pressure may occur in the form of characteristic pat-
terns or waves. Two distinct types of waves have been described by Lundberg:'
A-waves. Ominous episodic elevations of ICP to values of 50-100 mmHg (67.5-135
cmH.0) 5 to 20 minutes in duration, usually superimposed on an already
elevated baseline ICP. Also known as plateau waves. See example below.
B-waves. Short-term oscillations lower in amplitude than A-waves occurring at a rate of
12 to 2 fluctuations per minute. Clinically less significant than A-waves, but
B-waves occurring in runs in which the waves exhibit regularity in shape,
amplitude or rate tend to be associated with pathological depression of con-
sciousness and according to our findings, often precede the appearance of an
A-wave.
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Fii,ure 1. Typical A-waves re . :led with the fiber optic ICP
monitoring system. From: "Thc use of a fiber-optic intracranial
• r, sure transducer in clinical practice," b y A.P. Levin and L. Fraz in.
Presented as a Scientific Exhibit at the Annual Mooting of the American
Associat ion of Nourolo ,,ioal Surgeons, San Francisco, April 1976.
1 LuSl,lberg, N. "Continuous recording and con trol of ventricular fl uld
pressure in nourosurgical practice, Acta Psychiat. & Neurol. Scand.
(Suppl. 149) 36:1-193, 1960.
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these systems cannot be readily converted to the display of ICP waveforms
as they are designed for the short-term display of much higher frequency
waveforms. For commercially available displays, about 1,000 samples or
less are taken during the brief interval displayed on the screen. If a
display period of three hours could be achieved, then for 1,000 samples,
the requlting band width would be approximately DC-.05 Hz 0 cycles per
W,
	
This frequency limit is high enough to preserve the type B
waves (Figure 1) that have been observed in ICP data.
Specifications: The display format should be flexible to allow for the
unique requirements of different institutions. The most common configura-
tion would provide for a central CRT monitor which displays approximately
three hours of ICP waveforms from each of four patients. Remote displays
at the bedside may be desirable. Each display channel should be calibrated
for a pressure range of 0-200 cm H 2O with a bandwidth of DC-2 cycles per
minute or more. Patterns should be recognizable from a distance of 20
feet or more. The system should be able to display types A and B waves
as well as maximum, minimum, and baseline pressure changes exceeding setable
limits. Upon recognition of one of these conditions, both visual and
audible alarms should be activated. Additionally, a permanent copy of the
displayed information should be initiated and continued until the alarm
condition is reset.
Actions Taken: A search for applicable NASA technology has been initiated.
A biomedical monitoring and display system developed for JSC may be applicable.
Problem Originator: Dr. Allan B. Levin, Division of Neurological Surgery,
University of Wisconsin Hospitals, Madison, Wisconsin.
BA:eam Coordinator: Everis R. Engstrom.
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Problem VW-45 - Sorbents for
Detoxification of Uremic Patients
Help Wanted: Verification of NASA technology; more applicable NASA
technology; commercialization possibilities.
Abstract: An entirely new concept of detoxifying patients with chronic
reaal failure, through selective adsorption of uremic toxins with special
sorbents, is gaining popularity oil 	 clinical scene. However, there is
a need for effective urea removal. The NASA technology of recovering
potable water from urine b y the breakdown of urea in a biologic fuel
cell might be applicable here.
The Need: Passage of public law PL-92-603 as an :amendment to the Social
Security Act provided financial assistance to patients with irreversible
kidnev failure. The act has extended treatment to a patient pop,ilation
estimated at 30,000 in 1976. 1 Dialysis is ail expensive treatment. The
annual cost of dialysis was $14,000 in a hospital and $5,000 in the
patient's home in 1968. 2 By conservative estimates then, the annual
expenditure on dialysis in the United States alone is around $300 million.
In the past decade, considerable improvements have been made in the
design and development of membrane dialyzers. The principle of operation
of a membrane dialyzer lies in the osmotic gradient caused across the
semipermeable membrane which drives the mass transport of various solutes
from the blood, flowing on one side of the membrane, to a dinlysate on the
other. Dialysis suffers from various shortcomings, some of which, besides
the high cost, are: bulky equipment, need to immobilize the patient, need
for a toilet drain or a kitchen sink, infection at the point of entry/exit
in the patient's circulatory system.
ri
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Detoxification of uremic patients through selective adsorption of
'	 uremic toxins with special sorbents (a compound capable of selectively
binding the toxin) is an entirely new concept, developed in recent
I
years, which would hopefully overcome the di;:l'.vantages of dialysis.
There are two possibilities for the use of sorbents.
(1) Introduction of selective sorbents into the dialysate bath of the
artificial kidneys causes uremic toxins to be irreversibly bound as
they cross the membrane. This maintains a cons',nt, high concen-
tration _gradient for the transport of the toxins, thus requiring
very small volumes of dialysate which can be continuously regenerated
with the aid of sorbents.
(2) Selective sorbents for urea and other toxins can be directly fed into
the GI tract allowing the transport processes to occur across the sur-
face of the intestinal mucosa (see Fig. 1). 5 The sorbents then, with
the bound toxins, would be rejected along with the feces. This has the
great advantage of not requ=ring a c-nnec:;on with the patient's circula-
tory system. Once selective sorbents have been perfected, a slurry
made up of the dialysate solution and the sorbents can be allowed to
stay in an isolated loop of the small intestine (a technique developed
by Schloerb 3 and Clark  for dialysis treatment using large quantities
of dial y sate) over a period of time before replacement.
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Another approach in the use of sorbents in the GI tract is to
microencapsulate the different sorbents in a polymeric material
such as cellulose acetate butyrate. The microcapsules containing
stabilized urease, charcoal, ethylene-maleic acid, and various ion
exchange resins can then be administered orally. The electrolyte
balance then would be maintained by selective adsorption taking
place in the gut. Experiments done on animals by Gardner 6 and
Sparks  show promise in the effectiveness of this technique.
Thus, use of sorbents in uremia can greatly reduce costs and the tedious-
ness of today's dialysis procedures.
Molecules such as creatinine, uric acid, etc., can be removed by
using charcoal. Similarly, phosphates, potassium, and sodium can be
removed using various binders.
What is the Problem?
The main problem facing researchers in this area is the removal of
urea. Twenty gms of urea have to be removed in 24 hours to duplicate the
function of a normal kidney.
Specifications: Currently, stabilized urease, charcoal, oxystarch, and
oxycellulose are used in the attempt to remove urea. Urease converts
urea to CO 2
 and Ammonia (NH 3 ), while CO 2
 from this reaction can be
buffered and exhaled. NH 3
 has to be bound by a system such as the EMS
copolymer.
The effectiveness of oxystarch (oxidized starch) as a urea adsorbent
is controversial--Italian scientists Giordano et al. 6
 report it to be a
very effective sorbent, while the work of Maxwell et al. 6 seems to con-
tradict this.
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The effective mass of the sorbent capable of removing 20 gms of
urea/24 hours should be sufficiently low so that it can be included in
a person's daily diet or be directly introduced into the isolated
intestinal loop without an overburden. Therefore, a sorbent capable of
binding 40 gms of urea/Kg of sorbent is needed if one wishes to limit
the necessary mass of sorbent to 112 Kg per day.
But it is clear from current literature that a sorbent capable of
binding 40 gms of urea/Kg. of binder is not available. The sorbents used
in an unencapsulated form must function over a range of pH values (1.5-8.5)
as they pass through the GI tract. Also, presence of a compound similar
to the toxin intended for removal can swamp out the sorbent. Toxic
effects of the sorbents themselves have to be considered in the selection
of the ideal compound.
It has been found that certain microorganisms such as selenomonas
ruminantium not only degrade urea, by using it as their nitrogen source,
but also synthesize amino acids. 5 Therefore, cellophane tubes containing
these bacteria and other binders such as charcoal can be introdu c ed into
the isolated intestinal loop see Fig. 2).5
These bacteria, in the presence of glucose or fructose, could create
urease and amino acids.
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NASA Technology: Work was done under NASA research grants in the early
1960's attempting to recover potable water from urine. Several bacterial
species such as Proteus Vulgaris, A. Aerogenes and Serratia Indica were
investigated as to their ability to utilize various compounds associated
with human urine as their main carbon and nitrogen source (N63-20248,
"Biochemical Study of Mixed Culture Prototype in a Closed Ecologic System").
The reaults showed that only Proteus Vulgaris could convert 94-982 of urea
in the urine to NH 3 and/or microbial protoplasm. This and other relevant
NASA reports are being closely studied to determine the usefulness of their
contents in the above application.
Actions Taken: During a recent trip to Ames Research Center, the BAT coordi-
nator met. with Dr. Vance Oyama to discuss application of NASA technology to
this problem. Dr. Oyama feels that certain specific affinity polymers used
in space to gather organic molecules existing at very low concentrations
(parts per trillion and less) perhaps could be used in this application to
attract and irreversibly bind urea. Dr. Oyama was provided with a copy of
the problem statement for background information. There will be further
information exchange between Dr. Oyama and the problem investigator before
an accurate determination of applicability of this technology can be made.
References
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Problem UW-46 - Self-Contained Oxygen
Supply for Use by Patients with Chronic
Obstructive Pulmonary Disease
Help Wanted: Evaluate NASA technology; other NASA technology; commercialization.
Abstract: Some COPD (chronic obstructed pulmonary disease) patients
require the administration of supplemental oxygen to sustain even basal
activities or minimally exerting physical tasks. What is needed is a
portable, easily worn device capable of supplying oxygen to these patients
so they may be at least minimally ambulatory and have a more normal life.
Background: Oxygen therapy to relieve low blood oxygen and breathlessness
problems in patients with respiratory insufficiency has increased since
its introduction iu the mid-1910's. Present subject population is estimated
to be in excess of 80,000 in the United States. Other procedures are
employed including bronchial hygiene techniques and pursed lip breathing
to control expiratory rate. It is still necessary however, in more
severe cases, that the patient breathe an enriched oxygen mixture in
order to sustain arterial oxygen saturation approaching 95%. Fixed loca-
tion oxygen delivery systems for non-ambulatory patients are readily
available, both from large compressed gas cylinders and as systems for
extraction of oxygen from ambient air for delivery to the patient.
Portable systems for the ambulatory or even minimally mobile patient are
much more limited. Small, compressed oxygen cylinders with their attfnde.:.t
regulator and other accessories are quite awkward to wear by the patient,
particularly the elderly, and offer very limited storage capacity.
Chemically bound sources such as the chlorate candles suffer the same
disadvantage of short delivery time and, additionally, have relatively
high costs compared to other oxygen sources, as well as potential ignition
t
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hazards in the presence of hydrocarbon vapors. As a result, the most
commonly used system for semi-ambulatory COPD patients is a small dewar
delivery system which contains liquid oxygen. Such systems are sold by
Linde and others. These systems will provide up to four hours mobility
using a release rate of two liters per minute. The cost for the rental
of the portable unit and fixed reservoir system is often in excess of
$50 per month, not including liquid oxygen. Additionally, in all but
the largest metropolitan areas, the logistics of getting liquid oxygen
to the individual's home is very awkward.
The Need: The need is for an oxygen supplementation system, capable of
being worn or at least easily carried by the patient and capable of
supplying sufficient oxygen to permit basal activity and limited ambulation
to facilitate independence from continuous care by other persons. The
device should be reliable, amenable to operation by the patient, who
may be elderly or have limited physical capabilities for other reasons.
The system would ideally be equal to or lower in cost for annual operation
when compared to existing systems. As a point of reference, a COPD patient
requiring continuous administration of oxygen at an approximate flow rate
of two liters per minute would incur an annual cost in excess of $3,100
per year for oxygen.I
Target Specifications:
1. Weight - ten pounds or less.
2. Volume - occupy a volume of less than 300 cubic inches and be
so configured as to be comfortably worn by the patient.
3. The device shall deliver to the patient .75-2 liters per minute
of oxygen at STP, for a period of 1-4 hours. Concentration of oxy-
gen in the delivered gas to the patient should be greater than 90%.
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4. The system shall be suited for use with a nasal cannula delivery
system.
5. The system would ideally incorporate the capability of demand
operation, in which the administration of the oxygen is controlled
by the patient's inspiration/expiration cycle, so as to minimize
oxygen consumption.
6. The source of oxygen delivered to the patient or the supplies
from which the oxygen is generated or extracted should be
available readily throughout the United States, or a scheme for
widespread distribution widely established.
1. Cost of purchase/lease and operation of the device and its
requisite supplies should be less than the cost of existing
portable liquid oxygen delivery systems.
8. The design of the device shall be such that its routine operation,
supply replenishment, preventive maintenance and cleaning shall
be-capable of being conducted by the patient himself after
training.
Action Taken: A .iterature search has identified two potentially applicable
technologies for the wearable oxygen supply system. Contact has been made
with Pat McLaughlin of Crew Systems at JSC to explore possible use of a
high pressure, compact storage tank developed for the firefighters
breathing apparatus. Additionally, the oxygen enrichment system using
molecular sieves, developed for use by military aircraft for Wright
Patterson AFB, may be potentially amenable to this application. Contact
was made with Bendix Instrument and Life Support Systems in Davenport, Iowa,
developer of the aircraft system. While Bendix technical staff thought
that there might be merit in feasibility investigrtion of a wearable unit,
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marketing considerations resulted in focus upon an AC line-powered unit
(weight limit 41 Kg) for home use (see Figure T) to extract oxygen.
Titis interaction did, however, result in the provision to V.e Regional
Chest Center, of a prototype demand cannula system (see Figure 1) for
potential use with a wearable system.
Selector Switch	 Adjustment Screw
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DEMAND CANNULA
Contact was made with Mr. Norm McCombs, President of Xorbox Corporation
of Buffalo. New York. He indicated that Xorbox was Quite interested in the
proposed product concept and had expertise in molecular adsorption systems.
Another approach identified resulted from work done by Hamilton Standard
under contract to NASA. A wearable oxygen storage system, utilizing high
pressure cylinders, was constructed in a feasibility investigation. Efforts
are underway to obtain loan of the prototype for evaluation by Dr. Kass at the
Regional Chest Center.
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Problem VW-47 - Hand and Foot
Warmers for Patients with
Raynaud'a Syndrome
Help Wanted: Appropriate medical specialty; commercial products available;
actual extent of the problem (market size).
l	 Abs, tract: The local vasoconstrictor reflex that occurs normally during
exposure to cold becomes hypersensitive, mostly in the hands, of persons
with Raynaud's syndrome. Complete protection from cold is essential to
prevent excessive tissue damage. NASA space-suit technology is clearly
applicable. Comfort Products, inc., a company that manufactures hand
and foot warmers (derived from NASA technology) for winter recreational
activities such as skiing, has shown a great interest in extending this
technology to this clinical application.
The Need: Raynaud's syndrome is a condition in which exposure to cold
environments of various intensities, depending on the severity of the
condition, or emotional disturbances causes complete interruption of the
local blood flow by tight constriction of the arteries of the hands. A
study by Maricq at al. l shows that when the hands of patients with Raynaud's
syndrome are cooled to 16% there is a complete standstill of blood
flow even at the capillary level, as compared to normal subjects in whom
capillary flow is never interrupted even at much colder and longer cold
exposures. As a result of this, patients with Raynaud's syndrome exhibit
the classic triphasic color response in their hands when exposed to
cold; hands first turn white, then blue, and finally red. The hands
turn white initially due to the blood flow interruption, following which
hyperemia (the buildup of metabolites) in the tissue gives them a blue
tinge. The hyperemia subsequently triggers a hyperdilation of the blood
C' , -7—
vessels causing the redness and severe pain. Continued exposure to cold
can cause the fingers to become gangrenous.
Up until this year, two separate disease entities bad been defined
as showing the Raynaud's syndrome. These were Raynaud's disease, which
was thought to be a harmless, benign condition of unknown etiology, and
Raynaud's phenomenon, where the vasospasm occurred due to some underlying
systemic, immunologic, or connective tissue disorders. Advances made in
immunology have made it possible to show that latent disturbances in the
immunologic system also exist in patients with Raynaud's disease and that
these persons run a high risk of having diseases that cause Raynaud's
phenomenon.3
Some of the conditions that cause Raynaud's syndrome are rheumatoid
arthritis, dermatomyositis, scleroderma, systemic lupus erythematosus
(SLR), and occupational trauma, such as caused by excessive use of hands
in rowing a boat and operating pneumatic drills.
Rheumatoid Arthritis is a chronic disease of the joints marked by
inflammation of the cartilage surfaces and atrophy of bones. It is
estimated that this condition is responsible for more absence from work
and lower industrial productivity than any other single disease throughout
the world. It can strike anyone at any time in his life. About 702 of
those afflicted are in the 30-70 age group. In North America, the
incidence is 0.5-3.82 of all women and 0.15-1.32 of all men. 2 There is
evidence of autonomic nervous system dysfunction. Moving to a warmer
climate is recommended as part of the treatment. Although the exact
percentage of patients that get Raynaud's syndrome due to rheumatoid
arthritis is not available, all arthritis patients could be benefitted
from heated gloves or garments to relieve discomfort and pain.
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Dsrmatomvositis is a condition in which there is inflammation of
skin, subcutaneous tissue, and musales with the bsaskdows of muscle
fibers. it "aura mostly in the or group of 20-40 years * in the acute
form it could be fatal in a few weeks, but generally the disease become
ch„r,;c after relapses and remissions, and mortality is still high.
About one-third of all patients exhibit Raynaud's syndrome.
Scleroderma is a disease causing hardening of the connective tissue
of any part of the body including skin, heart, esophagus, kidney, and lungs.
Females are more frequently affected. An estimate of persons in the United
States with scleroderma is not available.
Systemic Lupus Erythematosus (SLE) is a disease that predominantly
afflicts women. In SLE, antibodies to DNA and cellular nucleic proteins
are formed by invading microorganisms or from the cells' own nuclear
components. The prevalence is 2-3/100,000. 2 The outcome of the disease
is usually fatal..
Sven though a close estimate of the number of persons that could be
benefitted by the hand warmers is hard to compute from the above discussion,
it should be apparent that the number is large.
Specifications: Due to different thresholds of different patients to cold,
the heat output of the hand and foot warmers should be variable. Exact
amounts of heat output necessary will depend upon the patient, the insula-
tion in the glove, and environmental conditions. Thus, they would have to
be designed for use with a variety of patients over a wide range of ambient
temperatures. Wounds heal slowly and infection is hard to control in
Raynaud's syndrome  so the gloves should be designed to protect the hands
from injury. The power pak for the gloves and the foot warmer must be
light and wearable with auxilliary inputs for power from an automobile or
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boat (aigarette lighter adapter) or the domestic 110 VAC line. The batteries
themselves should last at least one hear under maximam demand. Cosmatic.
appearance and comfort are also important design considerations.
Exact design specifications will have to be determimsd through use
of the gloves by patients and systematic data gathering.
MAU Technology: Comfort Products, Inc., Aspen, Colorado, is a company
that manufactures heated gloves and boots, derived from the NASA space suit
technology, for recreational skiing and other winter activities. The
BATeam coordinator contacted Mr. Dixie Rinehart, the designer of the NASA
space suit, now an employee of Comfort Products, Inc. Be indicated that
their company is ve:y such interested in this clinical application of the
space suit technology and, in fact, Comfort Products had even done some
preliminary work in tha area.
Actions Taken: One pair of the heated gloves were donated by the company
to be tried out'by a Raynaud's disease victim in Milwaukee, Wisconsin.
These gloves, called the "Lunar Mitts," were designed to be used by healthy
persons during winter recreational activities such as skiing. The patient
found the gloves to be inadequate for the following reasons.
The gloves contain the heating element only on the inside surface of
the fingers and rely on the normal blood circulation to distribute the heat
throughout the hand. This also acts as a heat sink to keep the temperature
of the heating element around 80°F. Blood flow in the hands of a Raynaud's
victim is reduced to <302 of normal flows So the patient found that the
back of her hands were too cold, while the heating element temperature rose
to the threshold of pain, due to improper heat distribution and heat sinking.
The BAT was contacted by Dr. Don Warren of the Wisconsin Foundation for
Applied Technology, Inc., a non-profit organization interested in technology
-i02-
application in health care, with regard to this problem. Dr. Warreng under
a grant from the Wisconsin State Division of vocational Rehabilitation is
developing heated glows for the very sue application. Due to common
objectives, the SAT will work jointly with Dr. Warren's group and Comfort
Products, Inc., in any further developmental work.
The gloves have been currently loaned to Dr. Warren for further evaluation
on another patient, a state employee in Green Bay. The data gathered will
be used to develop specifications for the new design.
A NASA literature search on thermal insulation has turned up several
leads on NASA technology used in space suits and gloves which will be
pursued during the next quarter.
Market Study: Due to lack of information on the incidence of Raynaud's
disease, a preliminary market survey was done by the BAT coordinator. The
following people/institutions were contacted for patient information.
Person/Institution
Dr. Marguerite Lerner
Yale Univ. School of Medicine
New Haven, Connecticut
Dr. George M. Gura
Mayo Clinic
Rochester, MN
Dean Clinic, Madison, WI
Univ. of Wisconsin Hospitals
Madison, Wisconsin
Madison General Hospital
Madison, Wisconsin
Reported Cases of Ra mud's Disease/1976
Inpatient	 Outpatient
N.A.	 24
N.A.	 336 (1974)
N.A.	 36
5	 N.A.
3	 N.A.
From this mini-survey, it is apparent that the majority of patients get
treated as outpatients. Only very few patients, in whom the primary disease
progresses to a critical stage, get admitted as inpatients.
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Both Dr. Our& and Dr. Lerner felt that then would be a good number
of patients who Mould be benefitted by heated glows. To obtain more
information on the incidence of Raynaud's disease on a nationwide basis,
a computer data search has been initiated throw the Visconsin Bureau of
Health Statistics—cooperative Health Data Project.
Bibliography
1. Maricq, H.R. ere al., "Standstill of flail Fold Capillary Blood Flow
During Cooling in Scleroderma and Raynaud's Syndrome," Blood Vessels,
13:338, 1976.
2. Harrison's "Principles of Internal Medicine," McGraw Hill, Seventh
Edition, 1974.
3. Porter, J.M. at al., "Clinical Significance of Raynaud's Syndrome,"
J. Cardiovas. Surge, 18, 101, 1971.
4. "Current Medical Diagnosis and Treatment," Ed - Kupp, M.A., Chatton, M.J.,
Lange Medical Publications, 1974.
5. Peacock, J.H., "Comparative Study of the Digital Cutaneous Temperatures
and Hand Blood Flow in Normal Hand, Primary Raynaud's Disease and
Primary Acrocyanosis," Clinical Science, 18:25, 1959.
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Problem W-48 - Treadmill for low
Use by Patients Kith Chronic Obstructive
Pulmonary Disease
Abstract: Rehabilitation programs for persons with chronic obstructive
pulmonary disease (COPD) involves, as an "poet of the regimen, the use
of graded exercise in order to maintain and improve pulmonary efficiency
in these patients. A low-cost, powered treadmill would allow such
exercise to be carried out conveniently and effectively in the home.
Background:  Rehabilitation programs for a variety of disabilities
including COPD and cardiac disease have become increasingly widespread
over the last 20 years. An expression of this has been the increase in
the popularity of jogging, development of consumer products such as low-
cost rowing machines, bicycle exercisers, and non-powered treadmills.
Many of these devices are primarily used by persons not involved in a
medically supervised conditioning program, and the exercise tolerance
and work expended are often quite subjective.
It has been shown  that close compliance with a graded exercise
program is necessary for the long-term improvement of COPD patients, who
number more than 500,000 in the United States today. Studies have
shown  that compliance with prescribed exercise using activities such as
infrequent walking in the patient's neighborhood achieves the degree of
improvement desired. Factors such as the weather, terrain and condition
of sidewalks, etc., however, introduce too much variability into such a
program.
The inexpensive devices presently available for exercise, because
of their construction economy, are not suitable for such a controlled
exercise program because it is not possible in the home to either calibrate
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or maintain calibration of rate and quantity of work done using the
extremely simple absorption loading systems typically employed. The
wide variation in patients' characteristics-and high average age indicate
that a device such as a treadmill would be preferable to a device such
as a bicycle exerciser because the treadmill would be easier to use and
has the advantage that larger groups of muscles can be exercised than is
possible with the bicycle exerciser.
The -Need: A lour-cost, reliable treadmill for use by MPD patients in
graded exercise programs in their homes is needed. The treadmill would
ideally require very simple operation and minimum maintenance by the
patient in order to maintain proper function.
Target Specifications:
1. Treadmill speed range: 1.5-4 miles per hour. Speed may be
fixed at 2-mph or optionally adjustable.
2. Elevation shsll be adjustable from 0 to 20' from horizontal.
Adjustment may be accomplished by bolting/unbolting or minor
disassembly.
3. The flat walking surface of the treadmill shall be a minimum
of 18 inches wide and 42 inches long.
4. Handrail assembly shall be readily demountable or permit
folding for storage to transport.
S. Weight of the treadmill assembly shall be less than 125 pounds.
6. The device shall not require preventive maintenance or adjust-
sent beyond the capacity of the patient more frequently than every
six months. Design service life shall be at least 800 hours.
19 Selling price of the treadmill should be less than $300.
.	 P
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S. The device shall require only 110 volts A.C. for operation and
consuns'lesa than 600 watts during operation.
9. Sound produced by the treadmill shall be less than 70 dbA.
Action Takens A major cost component of the treadmill is the motor and
its attendant costs. Minimising the frictional losses of the treadmill will
permit use of a smaller., lighter, and less expensive motor and drive
assembly consuming less energy. Coating of the support pan over which the
treadmill belt passes would minimise frictional losses and reduce size,
weight, and energy required.
A literature search has identified a technique developed for NASA for
applying a very hard, permanently lubricating coating to metals. This
method was utilized to solve the problem of the bellows for the Lunar
Orbiter camera "freezing" due to friction. It was also used on drills
used to obtain core samples from the lunar surface. This coating process is
commercially available from the General Magaplate Corporation, Linden, Now
Jersey.
The need for an exercise treadmill on Skylab 4 resulted in the design of
a simple, easily stored system which utilized teflon bonded to aluminum to
reduce friction on the walking surface. This system was used successfully and
played a significant role in maintenance of the crew leg muscles. An
adaptation of the elements of this system seem promising for a low-cost
device for graded exercise.
The specifications have been reviewed by medical personnel in
several areas of the country, and the target specifications refined and
expanded to encompass all required functions and constraints. Intent
has been expressed by two commercial concerns. One of these companies,
Uniwave Inc., of Elmhurst, NY will be coming to Madison in January 1918
to discuss construction of a prototype treadmill for evaluation of the concept.
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Problem VV-49 - Sleep Nonitoring System
Yelp Vented: IIG signal processing technology, spectrum analysis, recording
devices. Identify interested companies, complete design, arrange funding.
Abstract:  There is a need for a simple to use, inexpensive system capable
of monitoring EEG daring sloop in the home environment. Technology developed
to monitor BIG of the astronauts prior to, during, and after the Skylab mission
seems to have comercial potential in this application.
Th 	 An estimated 30 million people in the United States ( 152 of the
entire population) are troubled by sleep disorders of one kind or another.2
Sleep research, for the first tine, is gaining worldwide recognition u a
new clinical discipline (clinical polysomnography). Sleep disorders are
being studied, defined, and treatment regimens evolved. Sleep research
centers, being established in hospitals, have risen in numbers from 7 to
20 since 1970 . 2 Pharmaceutical companies have been developing products to
alleviate sleep disorders, the total market size of which is estimated at
$350 million.
The mainstay of sleep research has been the monitoring of brainwaves
(EEG) ever since the first classification of the electrical activity of the
brain by Loomis, Aarvc,- i Hobart in 1935 . 3 Sleep is classified into various
stages, the determination of which is based on the combined information from
BIG, EOG (electro-oculogram) and EKG (electromyogram). While EOG indicates
the activity of eye muscles, ING is a measure of skeletal muscle activity.
^.
	 The characterisation of sleep stages can be summed up as shown in Table 1.
Total sleep time and other major sleep parameters change with age and
sex. Progression of sleep in a normal young adult is shown as sleep stage
versus time in Figure 1. Voluminous data have been generated in the
study of these variables . 3.4 Since 1935, there has been a large accumulation
i
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Table 1
Activity
— — ^E	 omyost t ton
State Predominant FMC EOC
Awake a Waves	 9 Waves High High
8 . 14 Hz	 15-35 Hz
WvM"01 VAV-UA4
Stage 1 8 Waves	 a less	 than	 502 of above Low Low
0 Wav es 4-7 Hz
Stage 2 0 Waves	 Spindles-12-14 Hz bursts Low Low
b,	 ^^^ u 'D.5 seca.^K-complexes
Stage 3 6 Waves	 Reduced 8
0.5-3 Hz
W
	
150 a V 
Stage 4 6 Reduced 502
REM (ReW ess Eye Movement)	 Same as Stage	 1 Low High
as r..o ^^
w^.nc^ w«cv
.^wN.
° SLIP ' m	
liJ
1	 1	 7	 6	 6
Figure 1
Progression of normal sleep in a normal young adult.
i	
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t	 of research data pertinent to sleep disordersg am termed dyesomnies. Seas
of the more common disorders are described below.
f
s
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Ina=_ is by far the most cocoon sleep disorder. At the December
1976 sleep conference in now Torkg the results of a 3.000 physician surrey
jaw insomnia the top billing as 18.72 of all dyssomAias. Insosmia is widely
known as the inability to sloop in a norml environment.
Sleep Apnea is a disease wbere the victim stops breathing during sleep
for 20-130 seconds * forcing his to awaken. This can happen as any as 500
time during the night. 2 Most patients have such brief breathing interruptions
that they have no recollection of these episodes in the morning except for
daytime sleepiness, hallucinations, personality chan=ts and abnormal behavioral
outbursts. Sleep apnea affects more than 50.000 Americans. 102 Sleep apnea
is believed to be one of the causes of SIDS (sudden infant death syndro°e).
Marcy is a disease where patients are subject to irresistible and
overpowering daytime sleep attacks. The BATesm coordinator contacted Sill
Baird. President of the American Warcolepsy Association. According to
Mrs Baird, there are 250.000 narcoleptics in the United States by conservative
estimates.
There are manly other dyssounias. the discussion of which would be
beyond the scope of this statement. Dyssomniss can occur secondary to other
disorders such as renal insufficiency. nutritional disorders, thyroid
dysfunction, neurologic disorderso brain and spinal column lesions or
tumors. infectious conditions and mental retardation.
Sleep monitoring can help doctors to see if the problem is primary.
i.e., caused by an abnormal physiology or whether it is secondary, a result
of psychiatric or emotional problems.
=11i=
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Monitoring at now versus in Mospitai
both have their relative merits and disadvantages. Monitoring sleep
in a hospital allows the use of sophisticated equipment, expert medical
personnel and other medical services. However, it is very expensive,
space limited, and the change in the environment can make the patient
anxious and compound his problems at^least for the first few days.
It is our hope to develop a simple-to-operate, home-based 320 data
acquisition system enabling the patient himself to gather the data to be
processed by his clinical somnologist at a sleep center. preliminary
talks with the professionals in this field show that such a system can
have a high market potential in view of the growing recognition of
dyssomnias. The reduced cost of home monitoring can make diagnosis and
treatment available to a such greater section of the patient population.
RASA Technology
Sleep monitoring techniques for Skylab astronauts were developed with
a similar purpose. They bad to be simple to use by the astronauts, non-
intrusive and designed for remote processing of the data. A sleep analysis
system designed by NASA fot study of sleep in normal adults during space
flight is described in the "Skylab Sleep Monitoring Experiment (M133)" by
Dr. James D. Frost et al.s
". . . The complete sleep-analysis system designed for this experiment
included data-acquisition hardware, onboard analysis components,
and a capability for real-time telemetry."
"Onboard equipment accomplished automatic analysis of the electro-
encephalogram, electro-oculogram, and head-motion signals. The system's
output, consisting of sleep-stage information, was telemetered in near
i	 real time to Mission Control, where a profile of sleep state versus
xiF
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time was accumulated. The analog signals (electroancephalographic,
electro-oculographic, and head motion) were also preserved by onboard
magnetic-tape recorders, thus allowing a more detailed post flight
analysis."
"The components for the hardware are shown in Figure 2. (The
figure numbers were changed for this problem statement--ed.) The
astronaut wore a recording cap containing electrodes for detecting
electroancephalographic and electro-oculographic activity. A
preamplification unit, attached to the cap near the vertex of the
head, amplified the signals, and a dual-axis accelerometer, housed
within the preamplifier, provided information concerning movement of
the subject's head. A flexible cable connected the preamplifier with
a control-panel assembly . . . containing additional circuitry that
accomplished automatic electrode testing, sleep analysis, and generation
of the telemetry output signal, indicative of the subject's current
level of consciousness. Two tape recorders, attached to the rear of the
control-panel assembly, provided an analog record of the subject's sleep."
"The recording cap (Figure 3), made of an eleastic-type fabric,
stretches to conform comfortably to the subject's head. Inside the
cap, sponge-type electrodes are attached at the positions necessary for
acquisition of electroencephalographic and electro-oculographic signals;
wires join the electrodes to a miniature electrical connector at the
vertex of the cap, enabling rapid linkage with the preamplifier/
accelerometer assembly."S
A block diagram of the Skylab monitoring system is shown in Figure 49
which is self-explanatory. When the sleep stage information from the
automatic analyzer is plotted against elapsed time, a sleep plot is generated
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Figure 2. Skylab M133 sleep monitoring experiment hardware:
control-panel assembly (left) recording cal , and
preamplifier unit (lower right).
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Figure 4. Block Diagran of Sleep Monitoring System.
-116-
as shown in Figure S. A plot such as this can indicate deprivation of
various stages of sleep associated with dyssomnias.
As is, this system would be more elaborate and expensive then necessary
for home-based use. 8owever, any unique features of this system could be
directly used in developing a home-based 220 acquisition system.
The soft cap with the new disposable, prefilled electrodes (TSP-48C-
14623, "Disposable Biomedical Electrode") (Figure 6) would be such more
convenient for the patient to use than the individual electrode locating
and placement design. The automatic electrode function testing feature
can also be very useful. In the NASA system, as the astronaut activates
the test circuit, a small current (approximately 10 VA) passes in succession
through the single ground electrode to each of the recording electrodes.
In this manner, inter-electrode resistance is determined. If a given electrode
has achieved proper scalp contact (resistance 50,000 a or less), the lamp
corresponding to that electrode is illuminated. Improper contact is indicated
by failure of a lamp to illuminate, and the subject corrects this by gently
rocking the electrode in question from side to side to position the tip
through the hair.5
A preliminary design for a home-based system developed from these con-
cepts is shown in Figure 7. The final form, of course, would evolve from
joint efforts among clinicians, NASA scientists, and industry. A micro-
processor based "intelligent system" is indicated for versatility and
simplicity.
Actions Taken: The BATeam coordinator contacted Dr. Charles Pollack, Dept.
of Neurology, Sleep/Wake Disorders Unit, Montefiore Hospital, New York;
Dr, James Frost, Principal Investigator of Skylab sleep monitoring experiment;
and Mr. Bill Baird, President of the American Narcolepsy Foundation. All
three have shown great interest in this proposed project.
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Paton Plane:
1. Identify interested companies. Dr. Pollack and Mr. Baird be" offered
to help.
2. Seek support from National Institute of Mental Health (Dr. Jaliw 6ega1).
3. Jointly develop specifications for a home monitoring systu.
4. Build prototype.
S. Clinical testing to be carried out by company.
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Problem UW-50 - Improved Device for
Treatment of Esophageal Achalasia
Help Wanted: Evaluate NASA technology; other NASA technology; identify
interested companies.
Abstract: Esophageal achalasia, or failure of the gastroesophr:..•al junction
to relax, is successfully treated in some patients without sur,.°ry by
dilatation of the junction with an inflatable bag. Current d+lators do
not adequately monitor the degree of dilatation, with the resultant posse;--
bility of es^phageal perforation. A safer method of dilatation therapy to he
used in the management of achalasia is ne?ded.
Background: Esophageal achalasia is characterized by a failure of relaxation
of the gastroesophageal junction, the absence of peristalsis; from the bo.'v
of the esophagus, and the progressive dilatation of the body of the esophagus
which becomes a reservoir for undigested food (see Figure 1). Achalasia i
treated by dilatation or surgery. A mercury-weighted b3ugie may be used to
ail p te the esophagus up to #60 Fr, producing temporary and i , tcomplete relin_f.I
This can be used to improve esophageal drainage until the patient can be
offered more effective hag dilatation or myotomy at a later stage.
Figure 1. Esophageal Achalasis
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Bag dilatation was first described by Russell in 1898. 2 An Adaptation
of this water system, the Browne-McNardy air distension bag, was described
in 1"39 3
 and is still in common usage (see Figure 2). The pictured device
has been essentially in use for altnist 40 years. The manufacturer reports A
continuous sale of approximately 4 of the $500 units per month. The bags
are usually used as either fully dilated or not dilated. The bags ere
typically 45-50 mm in diameter with a pressure of approximately 9 PST when
fully dilated.
Since the early 1900's, forceful dilatation has been the conventional
mode of treatment for esophageal achalasia. Because good results are achieved
in only 65% of patients wilt significant complications in 5%, surgical
treatment has been used more frequentl y and with considerable success. There
Browne McNardy ddalnr uses air pressure in i -rift-clod cuff to 8100, controlled stress to the gasttorsopha
peal junction the comOnnent pa r ts are a ddatow bap wslh ry lurnrnp mesh to avoid overdrstensro r - an an
pump and a gauge The bag is inser ted under topical anesthesia and placed across the past oesep '^ayeal
junction using fluoroscopic control
}figure 2. The Browne-McNardy air distension bag.
Lo t
 howeverg a class of patients sot able to tolerate general anoodmia
for oboe bag dilitation is still the treatment of choice. The intended
mechanism of dilatation therapy is to produce sufficient dilatation to
tear the muscle of the gootrossopbapal junction without perforating the
esophagus. it is difficult with the current dilators to know Mbar the sw ooW
has been sufficiently torn without risking ssopbapal perforatios.
The good_: A device or technique to safer produce relantion of %be gastro-
esopbageal junction. Such a device would be used is patients with esopbspal
schaiasis for whom surgery is precluded. Additionally, if the degree of
muscle tearing could be more accurately monitored and the level of complica-
tions reduced, dilatation therapy would probably be used more frequently in
all types of sebelasis patients before surgery is resorted to.
Specifications: Dilatation of 50 me diameter is typically required to teas
the muscle of the gaetroesophageal junction but is variable from patient to
patient. Cood'data is not available so it would be desirable to have a device
which monitored degree of dilatation as well as indicating when the muscle
bad begun to tear. At a minimume the dilator should permit determination of
the initiation of =eels tearing any' prevent abrupt changes in diameter
which might perforate the esophagus. The dilator should be able to exert
a surface pressure of up to 12 PSI. The am device should not sell for
inordinately more than the carre:zt $500 devices. A modification of an existing
bag dilator which permits monitoring of bag diameter and prevents abrupt
diameter changes after initial muscle tearing may be the most straightforward
approach. Otber approaches such u wan-pneamatie mechanical dilators used
not be automatically rated out. however.
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Action Taken: A Rearch for applicable NASA technologv has been initiated.
It is possible that NASA strain Rage and pressure transducer technology is
applicable to the solution of this probl em.
 Additionally, if a volume-
driven system in used, the system shown in Figure 3, which was developed by
Lang l ey Research Center, might he used to --nse reek pressure /
 volume and
shut down the drive, preventing the possibility of esophageal performation.
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ACTIVITIES AND ACCOWLISMICHTS
BURNS ANALYSIS SYSTEM
At the suggestion of Mr. Ray Whitten, Read of Biomedical Applications
for NASA-TU, the UW-BAT assumed responsibility for the commercialization
of the JPL Burns Analysis System. Preliminary discussions of the subject
were carried out by phone with Dr. Victor Anselmo, the inventor of the
burns system and Senior Scientist in Biomedicine at JPL. Subsequently,
Mr. Burke O'Neal of the UW-BAT visited JPL on September 21-23, 1977 to
inspect the burns system and plan a commercialization strategy.
It was decided that a demonstration of the system should be held
for interested companies. While work proceeded at the University of
Southern California Burn Center in evaluation of the system, Mr. O'Neal
was to contact companies and make plans to hold the demonstration. To
avoid possible conflict with patient care at the burn ward, the demonstra-
tion was to take place at JPL.
Seven large companies with products in image forming diagnostics
were contacted. Of these, written interest in sending someone to the
demonstration was received from three and verbal commitments from three
others.
It was first decided to schedule the demonstration in late fall 1977.
Subsequent difficulties encountered gathering the data at USC pushed the
target date back to mid-March 1978. A report to the demonstration and
on subsequent efforts to speed the commercial development of the JPL burns
analysis system appeared in reports covering BAT activities in 1978.
PRECEDING PAGE St ANK NOT FILMED
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LIZISCOPE
One of the most promising applications for the GSFC Lixiecope is in
dentistry. Patients who are able to visit a fully equipped dental office
are able to benefit from the use of r-ray equipment for diagnosis. But
those who live in relative isolation or who are unable to visit a dentist's
Office, such .s some of the elderly and handicapped, often suet forego a
comprehensive diagnostic examination. The portable imaging device, the
Lixiecope, could be carried to the side of this latter population.
An a direct result of the activity generated by the UW--BAT to define
needs in dentistry amenable to solution with NASA technologies, the UW-BAT
accepted responsibility to help commercialize the Lixiscope, Mr. Bakki Kadve
not with the inventor of the Lixiscope, Dr. Lo I Yin, and others at GSFC
In May 1977 and also in October 1977 to learn about the device and plan a
commercialization.strategy. In November 1977 0 Mr. Kudva attended the
Annual Meeting of the American Nuclear Society in San Francisco as part of
the NASA contingent on hand at the meeting to announce the device, answer
questions, and solicit industrial interest in its application.
Independent evaluation of the Lixiscope will be carried out by
investigators at three separate sites: the NIB, Howard University, and
Duke University. To further the commercialization of the Lixiscope, a
demonstration conference is scheduled for aid-1978, at which time these
Investigators will present thlir findings. The UW-BAT will be responsible
for arranging the conference. To help develop a sailing list of prospective
attendees, the Team prepared a list of x-ray manufacturers in the United
States and provided this information to the GSFC TU Office.
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E	
PROCTOSICKOIDOSCOPE
At the request of Dr. DoWlas A. O'Bandley' At the Jet Propulsion
Laboratory, the UV-BAT did a preliminary investigation of the conmercial
potential of an improved proctosigtoidoscopo, a design which resulted
from a RASA-sponsored study entitled "Feasibility Study on the Design of
a Probe for Rectal Cancer Detection" (JPL Publication 77-31). A mockup of
the proctosi.gmoidoscope, developed by Mr. R. E. Frazer of JPL, was shown
to provide an extremely wide angle of vision. A patent application has
been filed. Each year there are approximately 100,000 new cases of and
50,000 deaths from colorectal cancer. Numerous physicians and researchers
believe that there is a great need for increased mass screening for
colorectal cancer. Cost-effectiveness, however, of mass screening for
this disease is still controversial. One issue is that the procedure
should be made more agreeable for patients. Some physicians also believe
that it is important to reduce the cost of an exam by making better use
of technicians. Others believe that once the patient is prepared, the exam
can be completed in 3-4 minutes by a physician. Consequently, such physicians
tend to object to the further use of paramedical personnel. Currently, some
major clinics rely almost exclusively upon technicians to perform procto-
sigmoidoscopy, but the practice is not widespread.
UW-BAT personnel interviewed two former presidents of the American
Society for Gastrointestinal Endoscopy and found an acute difference of
opinion, both as to the need and also the potential market for an improved
proctosigmoidoscope. One believed that the most time-consuming part of the
procedure was proper cleansing of the bowel. Feces tends to adhere to polyps
and cannot be adequately removed with an enema. The other suggested that
an endoscope which provided good retrograde vision would be useful to
i.. 	 i
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t
visualize lesions near the anal canal and for checking for hemorrhoids
near the end of an azan* both agreed that an animal test would have to be
conducted before any new device is evaluated clinically.
Subsequent to the initiation of the SAT investigation, JPL decided not
to pursue further development of the device at this time. Meanwhile. the
California Institute of Technology has reportedly decided to apply for a
waiver of patent rights to this device and plans to independently pursue
licensing arrangements. The UN-BAT prepared and sent to JPL a list of
eminent endoscopists interested in the evaluation of the device. Further
e6forts to commercialize the device will be deferred pending a renewal of
Interest at JPLe
e	 a	 e	 e	 e
BRI9F REVIEW OF OTHER NOTABLE ACCOMPLISHMENTS
Electrode soft caps developed for EEG monitoring of astronauts
were provided to two groups of investigators for separate evaluation.
These applications were for driver alertness monitoring (in the report
covering last quarter 1976) and for the diagnosis of petit =1 epilepsy
(in the report covering first quarter 1977).
A satellite demonstration of the transmission of ECG signals from
remote ambulance to a medical center was planned for the Iowa State
Department of General Services. Meetings were held, under UW-BAT sponsor-
ship, at the GSFC between representatives from the Iowa state government
and the GSFC Applications Engineering Office (see quarterly reports for
the second and third quarters, 1977).
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Planning for a TU-RTOP on Advanced Hearing Aids for Children involved
one member of the UW-BAT. A seating involving people from several TV
units as well as representatives of non-NASA federal agencies Mae held.
Requirements were discussed and an announcement prepared for distribution
to NASA field centers to solicit proposals (see report on third quarter,
1977).
e	 e	 e	 *	 e
INACTIVATED PROBLEM STATEMENTS
Title: An Unobtrusive Device for Suppression of Acoustiomotor Epilepsy
UW f:	 7
Daee of Inactivation: October 1977
Reasons: a) BAT project completed.
(b) Epilepsy Foundation notified of availability of device.
(b) Commercialization unlikely.
Title: Family Practice Clinic Design
UW F 11
Date of Inactivation: October 1976
Reasons: a NASA project completed.
(b) Models of patient demand and services rendered were
delivered by NASA.
(c) Management tool--commercialization unlikely.
Title: Human Engineering Factors in Hospital Communication Design
UW :	 16
Date of Inactivation: December 1977
Reasons: (a) Transfer of NASA information completed.
(b) Specialized application--widespread market unlikely.
(c) No plans for further application.
Title: Early Stroke Detection
UW W. 19
Date of Inactivation: December 1977
Reasons: a Long, unproductive active period (two years).
(b) No NASA technology identified.
(c) Research--no commercialization planned.
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Titles Abnormal Brain Wave Detection
W to 20
Date of Inactivation: December 1977
Rea_: a Long. unproductive active period (two years).
(b) No NASA technology identified.
(c) Research--no commercialization planned.
Title: Non-Silver Dearing Film for X-ray Use
UW : 22
Daee of Inactivation: December 1977
Reasons: a) More research needed on proposed NASA solution--exposure
sensitivity too low.
(b) Commercial partner could not be found.
(c) Since industrial application looks easiest, the NASA/MAT
agreed to assume lead role in future commercialization efforts.
Title: Ruggedized Cable Assembly for Patient Control of Nurse Alerting
and Environmental Control System
UW !:	 25
Date of Inactivation: April 1977
Reasons: (a) System needing improvement rapidly going out of use.
(b) Problem with existing commercial product--new commercialization
unlikely.
Title: An EEG Switch
26
Date of Inactivation: December 1977
Reasons: W' No NASA technology identified.
(b) Research--no commercialization planned.
(c) Similar to work being carried out by another BAT (Stanford).
Title: Unobtrusive Alertness Monitor
W 27
Date of Inactivation: December 1977
Reasons: (a) Commercial solution found.
(b) NASA technology identified, but found to be inappropriate.
(c) Researcher no longer strongly interested.
Title: A Telemetry Device to Monitor Loading and Stress Patterns in
Metallic Implants
UW fs
	
28
Date of Inactivation: April 1977
Reasons: (a) Information transfer completed.
(b) NASA technology based system is commercially available from
Konigsberg Instruments on a custom-made basis.
(c) Equipment loan from Ames was not feasible.
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Title: Highly Regulated Differential TOmpereture Control Systen
NW 29
Sat of Inactivation: October 1976
`t a Inforeation about applicable NASA system given to investigator.
(b) Research--no commercialisation planned.
Titlet Improved Pump System Reliability for Rztended Circulatory Bypass
W 31
Date of Inactivation: October 1977
Reasons: Problem originator found alternate Mays of getting around the mech-
anical fatigue and spoliation problems found in silastic tubing.
(a) Segmented polyurethane tubings are available commercially
that outlast silastic by 200 to 3002 without spallation.
(b) Bio-Medicus, Inc., 15307 Industrial Road, Himetonka, W
55343 has started marketing a centrifugal blood pump by the
trade name Bio-Pump' that completely eliminates the spallation
problem found in roller pumps due to the fact that the tubing
Is not subjected to compressive stresses.
Title: Reliable, Inexpensive Relative Humidity Transducer
UW ^: 36
Date of Inactivation: April 1977
Reasons: a Problem apparently solved with commercially available device.
(b) No NASA technology identified.
Title: Home Water Filtration Device
U 36
Date of Inactivation: December 1977
Reasons: a Problem can't be well defined yet.
(b) Commercialization impossible until non-technological issues
better resolved.
Title: Absorptiometric Techniques
W 40
Date of Inactivation: December 1977
Reasons: (a) No NASA technology identified.
(b) Research--no commercialization planned.
Title: Microwave Blood Warner for Extracorporeal Circulation
U
	
44
Date of Inactivation: October 1977
Reasons: a Low market potential.
(b) Technology expensive compared to conventional methods.
a	 a
ii
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TRIPS AND COE1►ERENCES
Travel by members of the Teas has been divided into several categories
according to the primary purpose of the trip. Visits arranged to present
the TU/BAT program or carry on discussions with project leaders are grouped
under Presentation and Discussion. The other categories are self-explanatory.
Conference Attendance inc uElie rregularly scheduled trade or professional
meetings, specieI workshops, and meetings for which NASA was a co-sponsor.)
A. PRESENTATION AND DISCUSSION
University of Nebraska Medical Center, Omaha, NS (October 12-13, 1976).
First visit to make contacts and establish liaisons. (Rouge)
University of Illinois 6 Northwestern Universit', Chicago, IL
October 13-14,  1 6 .
First visit to make contacts and establish liaisons. (Kudva)
University of Iowa Medical Center, Iowa City, ZA (October 21-22, 1976).
First visit to sake contacts and establish liaisons. (Engstrom)
Brown University, Providence, RI; Harvard Dental School, Cambridge, MA;
Peter Bent Brigham, Cambridge, MA; Children s Hospital, Cambridge, MA;
Massachusetts General Hospital, Boston, MA; i MIT, Cambridge, MA
November 10-12, 1976).
First visit to sake contacts and establish liaisons. (Kudva)
University of South Dakota Medical School, Vermillion, SD (November 14, 1976).
First visit to sake contacts and establish liaisons. (Rouge)
South Dakota State University, Brookings, SD (November 15, 1976).
First visit to make contacts and establish liaisons. (Rouge)
University of Cincinnati, Cincinnati, OH; and Area Rom itals (Move 14-18, 1976).
First visit to sake contacts and establish liaisons. 7Kudva 3 O'Neal)
Visit with Barry Simmons, Athens, GA (December 11, 1976).
Discussions of possible applications of NASA technology in remote
dentistry (UW-35). (Kudva)
Marquette Dental School, Milwaukee, WI (February 18, 1977).
Visited Dr. Robert Mallien to discuss application of NASA technology in
portable dental equipment developed there. (Kudva)
University of Minnesota, Minneapolis, MN (February 25, 1977).
Presentation to the Biophysics Gtoup and their guests, of the TU-BAT
program and possibilities for future interaction. (Fetaner)
F
^. o
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University f Nebru	 , Oaba, NB (August 4, 1977)o
Contacted personae
	 lonal Chat Center (Drs. Rase,
Bell, Fix, and Jensen) in response to letter of inquiry from Kass to
Don Vargo (KT). Investigating technology
 transfer opportunities In
area of long-term treatment of chronic obstructive pulmonary disease.
(House)
meeting
 on Satellite Demonstration, GSFC, Osesabelto NO (September 13 9 1977).
Scheduled to bring together personnel from the Iowa Division of Consual-
cations and representatives from the Office of Applications at GSFC to
consider plans for a satellite transmission of BITS communications in
Iowa. (Engstrom)
Geor a Washington UniversitY i St. Louis University, St. Louis, NO
Oct. 27-29 9 19 .
Contacted staff and faculty members at the two universities to acquaint
then with the RAT program and seek out problem areas for further
Interaction * (Souse)
Wayne State University , Detroit, KI, i university of Michigan,  Ann Arbor, MI
October 2 -28, 1977).
Initiate discussions regarding the UW-BAT program. Gave a talk at Um on
NASA programs in biomedical technology transfer. (Fatzner)
Western Research Application Center, Los Angeles, CA (November 11, 1977).
Met with Radford icing, Director of this NASA-funded organization.
Purpose--explore possibilities for cooperative activities between the
Ulm-BAT and WESRAC. (Kudva)
University of Arizona, Tucson, AZ (November 10, 1977).
Talk with physicians and others about their petit mal project--a study
based upon previous work by the UW-BAT. Also met with other physicians,
engineers, and scientists to generally discuss the UW-BAT program.
(Fetzner)
University of Washington, Seattle, and Good Samaritan Hospital, Portland, OR
August 21-22. 1978).
Invited to must with hospital administrators and doctors to discuss
needs of elderly and handicapped. (House)
5, VISITS TO NASA FACILITIES
Lewis Research Center, Cleveland. ON (November 23-24, 1976).
Discussion of potential application of a patented NASA process to
produce images on x-ray films (UW-22). (Fetzner)
Johnson Space Flight Center, Uoustmn. TX (December 13, 1976).
Met with TU Officer to discuss project UW-35, remote dentistry. (Kudva)
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Ames Research Center, 11offett Meld. CA (March 18, 1977).
Tony
 of life scieace laboratories and discussions
	 UM mplayeas
of issues related to current SAT problem statements. (Fetsner i tudva)
Marshall Space Fli bt Center, MSFC, AL (March 31 9 1977)9
Discussed methods 1ailesisating closer interactions with TU Officer.
Specifically discussed stereoscopic display system and evoked response
auditory testing. (Engstrom)
Goddard Space Flight Center, Greenbelt, MD (May 18-20 9 1977).
Meeting regarding UU-SAT project on dental equipment. (Madva)
Lewis Research Center, Cleveland, ON (August 25, 1977).
Meeting regarding nickel-based x-ray film project. Resulted from
Interest expressed by Picker Corp. in this tecbnology. Two Picker
representatives attended, along with TU personnel and scientists from
LeRC. (Fetzner)
Jet Propulsion Laboratory ►, Pasadena, CA (September 21-22, 1977).
Discussed state of the multispectrai analysis project and Implications
for commercialization. Reviewed applications to burn diagnosis and
to analysis of tissue viability. (O'Neal)
Goddard Space Flight Center, Greenbelt, MD (October 17-18, 1977).
Attended meeting on LIRI scope to discuss commercialisation possibilities.
Not with other researchers at center on separate topics. (Kadva)
Jet Propulsion LaboratoE , Pasadena, CA (November 10, 1977)
Contacted personnel as part of ongoing interaction between the UW-SAT
and field center. (Kudva)
Kennedy Space Flight Center, Florida (November 22, 1977)9
Took part in meeting on proposed merger of NASA and other programs in
area of computer-aided medical diagnosis. Talked with Dr. Buchanan,
KSC Biomedical Office Director, about UW-SAT project involving the
NASA IMSS Checklist. (Petsner i two guests from the University of
Wisconsin: Dre. Renner and Currie.)
Ames Research Center, Moffett Field, CA (November 30-December 1, 1977).
Discuss current UW-BAT projects involving personnel from this center
and explore possibilities for future interactions between UW-BAT and
ARC. (Kudva)
NASA TU Headguuarters Office, Washington, DC (March 31-April 1, 1978).
Not with Ray Whitten and others to discuss the contract extension
project.
CO TU-SPONSORED MEETINGS
NASA-MSFC Contractors Technology Utilization Worksho Chicago. IL
February 10, 1977).
Participated with contractor representatives. NASA officials, and IITRI
Team in discussions of new technology reporting requirements.
(Fetzaer 6 Kudva)
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TV Rating at IITRI. Chicago. IL (RMrch 30-31, 1977).
Discussions of RTOP policy and pluaing between field canter and Team
representatives. (Yetsuar)
Aam 1 RASA TU C nfereaas Washington, DC (May 23-26 9
 1977). (Huston i Fetanar)
Meeting of representatives from all UAWTV units.
Biomedical RIO? I iew. BTU, Baltimore. ND (July 21-22. 1977).
Participated in panel review of FT 0 78 Siomediaal RM I s with repre-
sentatives from several HAWTU units. (RFetsner)
PlannIM Session for PWTU- Neartma Aid Pro t. Washington. D.C.
July 26, 1977).
Mat with representatives from DREW and W.WTU to discuss solicitation
of proposals from 1fASA field centers to develop an advanced hearing aid.
(Fetsner)
!Meting with TU ReadSuarters Personnel, Washington, D.C. (November 2 1, 1977).
Discuss UW-HAT programs, particularly work on problems of the aged.
(Engstrom)
Review of UW-BAT Prom, Nashington. D.C. (December 7-9, 1977).
Presentation of work accomplished by the Team as part of a general
review of all SAT's by TU Headquarters personnel. (Fetsnar)
Ca_ et College. Washington, DC (October 17. 1978).
Attended workshop conference, as requested by TU Headquarters, to
participate in discussions of a new RTOP and learn about possible
applications of a device for the elderly and handicapped. (Rouge)
D. SITE VISITS TO MANUFACTURERS
Meeting with Ronemmll Corg, and Nero Clinic, Minneapolis. MN
(August 2-3, 1977).
Joined a contingent of !RASA visitors to Honeywell and Mayo Clinic to
learn of efforts there in stereofluoroscopy. Discussed NASAIJSC
proposal in this area. (Fetsuer)
Sendix Cory.. Davenport, IA (September 29, 1977).
Invited by engineering manager for Health Care Products of BOWIX
Instruments and Lifs Support Division to discuss their proprietary
Interests in a wearable oxygen supplementation system (UW-46). (Rouge)
Mee_ tint onBATProject, Milwaukee, WI (November 3, 1977).
Talked with private physician and company representatives MH Composites)
regarding holding tank design and application. (Kudva)
E. CONFERENCE ATTENDANCE
fteritoncy Medical Services Communications Seminar, Collage Park, Mb
(August 9-10, 1976. (Engstrom)
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NBRAC Seminar, Storrs, Cf (September 21-22, 1976).
set ng arranged by NAWIAC. (RuetoO
Annual air a
	 ri	 Coil	 f	 ,Chicago, IL(October 10-12 1 
	 .
Major medical conference ("or 17 6000 attending)= opportunity to pain
parspectivea and sake contacts. (Rndva)
Annual SglLerence on bmtoftrlu is icing sM Siol9ne laston, MA
r 6-10, 1976).
Major bloeogineering conference (over 1 9000 attending); four papers
presented by members of MTow= opportunity to gain perspectives and
sake contacts. (Engstrom, Fetsuar, Radva)
Annual Conference of SocletY for Advanced Medical Systese l, Boston, MA
November 10-43 9
	.
Forum for consideration of broader design factors, such as social.
contest, organisation of resources, etc., regarding health care
applications of technology. (Fetaner)
Technical AdvisoEl Seminar (sponsored by the Governor's Committee for People
with Disabilities), Madison, WI (November 19, 1976).
Invited to help prepare state plan regarding technical help for the
handicapped. (Fetaner i Rouge)
American Institute of Chemical Besiegers Regional Mastint, Minneapolis, MN
(February 24, 1977).
Gave talk entitled "The NASA Eartb Mission," as an invited speaker.
(Fetaner)
12th Annual Meetiat of the Association for the Advancement of !'.edical
Instrumentation, San Francisco, CA (Mesh 13-17, 1977).
Attended to obtain informstion on state-of-the-art in a diversity of
biomedical engineering areas and to make contacts related to RATeam
work. (Fetaner i Kudva)
National EMS Communications/Transportation S
	
slum, Atlanta, CA
March 29-30, 1
Reported on NASA communications channel quality monitor, NASA hospital
emergency console and possible EMS satellite applicatiorva. (Engstrom)
VA/NASA Conference on Habitability in the Extended CAre Environment,
Minneapolis, MN (September 21-23, 1977).
Attended as part of contingent from NASA to explore possibilities of
continued interaction in this area and for technology transfer to problems
of the aged. Report from Team sent to RT. (Engstrom, Fetaner, Rouge)
Trauma Symposium, Madison, WI (September 30-October 1, 1977). (Engstrom)
105th Annual Meeting of the American public Health Association, Washington, DC
October 31-November 3, 1977).
Made contacts sad learned about current issues and problems in field of
public health. (Engstrom)
OFk
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MIR Instrumentation Symposium, Washington, DC (November 2, 1977).
Learned about state-of-the-art in biomedical instrumentation field from
NIB contractors. (Engstrom)
30th Annual Conference on Engineering in Medicine and Biology, Los Angeles, CA
November 5-11, 1977).
Major annual meeting in the field of biomedical engineering. Gathered
Information on state-of-the-art, made contacts, follow-up on previous
interactions. (Fetzner b Rudva)
Annual Meeting of the American Nuclear Society, San Francisco, CA
November 28-29, 1977).
Represented e'ff'orts of UW-BAT to help commercialize the GSFC LIXI scope,
which was pry: +E- rated at the conference. (Rudva)
Workshop Co-Sponsored by NASA and NIA, Baltimore, MD (December 8, 1977).
Discussions of problems of the aged with the goal of exploring oppor-
tunities for NASA to transfer its technologies to this field. (Fetzner)
13th Annual Meeting of the Association for the Advancement of Medical
umentation (!March Z9-31, 19113).
Major national conference in medical device field. Gathered
Information and contacted people to prepare new problem
statements. (Engstrom)
*	 *	 *	 *	 *
SPECIAL REPORTS
Along with regular reports called out in the contract, Team members
prepared a number of special reports during the contracting period. A list
of these special reports follows, with each entry accompanied by the purpose
of the report, identification of the intended recipients, and the date that
the report was submitted.
* Distributicn of Team Resources
Prepared for Len Ault as part of agency-wide survey related
to cost containment planning (June 7, 1977).
* Team Status Summary
Prepared for Ray Whitten, Headquarters, Manager of the Biomedical
Applications Program, to provide information to be used in a
report on all BAT's (August 23, 1977).
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* Jointly sponsored NASA/VA conference ("Habitability in Extended Care
F	
Environments")
Report by attendees from the UW-BAT, prepared for Ray Whitten of
r TU Headquarters (October 25, 1977).
* RTOP Assistance
Aid given by members of the UW-BAT to Headquarters and field center
personnel as part of the preparation of FY 1 78 TU biomedical RTOP's.
Documents of various types (detailed letters, proposals, and reviews)
were written for six planned projects (April-August, 1977).
* Reconfigurable Information-Communications-Display System
Report delivered to NASA/TU Headquarters completing one of the
tasks 04) identified in the contract extension work statement.
s
f
s
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SECTION V
CONTRACT EXTENSION PROJECT
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CONTRACT RZTENSION PROJECT
Conception of the Plan
Along with other operating units of the NASA Biomedical Applications
Program, the UW-BAT began in late 1977 to concentrate attention on possibilities
for the transfer of NASA technologies to help elderly people in this country.
As one part of this effort, the UW-BAT pro:.%o*,tsd to study, in more depth
than usually given to problems, the specific needs of the aged and to
search for applicable NASA technologies.
Plans for such an in-depth study were formulated near the end of the
period originally designated for the BAT contract (July 1976 through
December 1977). These were submitted to the contract monitor at GSFC
as a request for a no-cost contract extension to complete the cited study.
After concurrence with TU Headquarters, the request was granted. The
original extension was for six months, but a subsequent request from the
Team for extension through calendar year 1978 was also granted. This
project, therefore, was conducted during calendar year 1978 as the sole
activity under the contract in force during 1977. Regular BAT operations
during calendar year 1978 were conducted under a separate contract, reports
for which are provided as separate documents.
The present discussion is a summary of work done on the special
project. A full presentation of this work can be found in the report
entitled "Definition of Problems of Persons in Sheltered Care Environments,"
submitted simultaneously, but under separate cover by the UW-BAT.
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Statement of Nork
Task 1: Gather information on the subject from medical doctors,
nursing home administrators, researchers, government workers,
special projects operated to meet needs of the elderly, industry
sources, and published documents. Organize this information to
define and characterize needs of the elderly, paying special
attention to those needs that seem to offer opportunities for
the new application of technologies. The contractor shall prepare
a list of these needs, arranged in some useful order of importance
in terms of the overall goals of the project.
Task 2: The contractor shall search for NASA technologies applicable
to the needs of the elderly living in sheltered environments. These
candidate technologies shall be identified in documented form.
Matching of identified technologies with defined needs shall be
attempted for those needs ranking highest in importance.
Task 3: An effort will be made to attack at least one matched need/
NASA solution in depth. A strategy for implementing the solution
will be developed. This will be forwarded to the technical monitor
for consideration, either as an RTOP draft or alternate plan of action.
Task 4: The contractor shall make other recommendations as appro-
priate in order to make best use of the information derived under
this extension.
Task S: A planning workshop shall be conducted. The subject of the
workshop shall be to examine, in depth, the application of NASA
technologies to one or more needs of the elderly living in sheltered
-1a7-
environments. Results of this planning effort will serve as the
basis for the involvement of field center staff in the application
of NASA technology to these needs through an RTOP arrangement.
Task 6: A small-scale demonstration of an actual application of
aerospace technology to one of the identified needs will be conducted.
A report giving details of the application and results from the
demonstration and potential for comsercialization will be produced.
Task 7: A final report will be prepared sussarizing the work done
on each of the tasks, as well as directions established, activities
completed, and RTOP's written as a consequence of this extension
project.
Accomplishments
A thorough study of the problem was undertaken by the UW-BAT through
meetings with gerontologists, nursing home operators, private foundations,
industry representatives and groups for the elderly. Out of these dis-
cussions, a long list of needs was prepared. The list was carefully
considered by others not involved with the list preparation to rank the
relative importance of the needs in several categories. These categories
included the scope of expected benefits, technical feasibility, and
applicability of NASA technologies. From the ranked results, a selection
was made of those most likely to benefit from increased NASA attention
(Task 1).
Next, a wide search of applicable NASA technologies was conducted,
concentrating on those most appropriate to the highest ranked candidates
above (Task 2). The best fit resulted in the selection of one problem--
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the lack of a systeas approach to the provision of aids and controls to
the elderly--for study in greater depth (Task 3).
Specifications for the proposed solution to the probleu involving
extensive applications of NASA technologies were developed. Recommendations
for concerted NASA action based upon the chosen problem and solution
specifications were addressed to NASA field center and headquarters
officials (Task 4).
While awaiting a NASA response to the above recommendations, the Team
organised and held a planning workshop to bring the views of more people
into the project (Task 5)9 Out of this meeting, another set of recommenda-
tions was produced to guide efforts to carry forward work on the chosen
problem over a wide spectrum of possibilities.
Besides concept planning, the Team applied some of the ideas being
considered to a small-scale demonstration of a prototype system. This was
developed in cooperation with local health and industry officials. It
was shown, in operation, to the contract technical monitor, Mr. Donald
Friedman, and the TU Biomedical Applications Program Manager, Mr. Raymond
Whitten, during a site visit of the UW-BAT in November 1978 (Task 6).
It was intended, when the project was conceived, that the Team would
screen the enormous number of special needs of the elderly in an attempt
to uncover those anenable to solution under the NASA TU program. We have
completed such an analysis, made specific recommendations, and demonstrated
a prototype embodiment of an idea that we believe merits further action by
TU. Now the task is to bring the concept to full-scale development, a goal
that will be pursued by the UW-BAT under its normal contract responsibilities.
APPENDICES
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APPENDIX A
PROBLEM STATEMENTS CONSIDBRED mmac REPORT=c PERIODI
Number Title
status 
UW-6 Unobtrusive Biofeedback Device for Treatment A4
of Petit Mal Epilepsy
UW-7 An Unobtrusive Device for Suppression of IS
Acoustiomotor Epilepsy
UW-10 Coating of Chronically Implanted Electronic A5
Assemblies
UW-11 Family Practice Clinic Design 14
UW-15 Wide Area Medical Communications A6
UW-16 Human Engineering Factors in Hospital i8
Comsun,ication Hardware Design
UW-19 Early Stroke Detection I3/I6
UW-20 Abnormal Braiu Wave Detection I3/I6
UW-22 Non-Silver-Bearing Film for X-Ray Use I4/I7
UW-23 Conformable and Autoclavable Return Electrode A5
for Electrosurgery
UW-24 Automated Patient Tracking System A2
UW-25 Ruggedised Cable Assembly for Patient Control of 14
Nurse Alerting and Environmental Control System
UW-26 An EEG Switch I3/I6
1 Previously inactivated problems have been deleted from list.
2 Status at the end of the reporting period. 	 For an explanation of status
codes, see the following coding keys on active (A-type) and inactivated
(1-type) problems.
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N= Ti status
UW-27 Unobtrusive Alertness Monitor I8
UW-28 A Telemetry Device to Monitor Loading and Stress 14
Patterns in Metallic Implants
UW-29 Highly Regulated Differential Temperature Control 14
System
UN-30 Multi-Spectral Analysis of Tissue Viability A3
UV-31 Improved Pump Reliability for Extended I9
Circul4tory Bypass
UW-32 New Femoral Mead Prosthesis Design to Improve A4
Long-Term Stability
UW-33 Miniaturised Force Transducer for Gastrointestinal A2
Motility Studies
UW-34 System to Provide Quantifiable Vestibular Stimulation A2
and Motor Response in Children with Delayed
Development
UW-35 Portable Dental Equipment A5
UW-36 Reliable, Inexpensive Relative Humidity Transducer I9
UW-37 Primary Care Education and Response A5
UW-38 Home Water Filtration Device 16
UW-39 Pupillometer--A Device to Continuously Measure A4
Pupil Diameter
UW-40 Absorptiometric Techniques I3/I6
UW-41 Design Improvements for Neonatal Intensive A3
Care Incubators
UW-42 Diagnostic Radiographic Image Storage System A2
UW-43 Intracranial Pressure Display/Alarm System A2
UW-44 Microwave Blood Warmer for Extracorporeal Circulation I4
UW-45 Sorbents for Detoxification of Uremic Patients A3
UW-46	 Self-Contained Oxygen Supply for Use by Patients 	 A3
with Chronic Obstructed Pulmonary Disease
UM-47
	
Hand and Foot Warmers for Patients with	 A7
Raynaud's Syndrome
UW-4P	 Treadmill for Home Use by Patients with Chronic 	 A5
Obstructive Pulmonary Disease
UW-49	 Sleep Monitoring Systems 	 A3
UW-50	 Improved Device for Treatment of Esophageal Achalasia A2
r'
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APPENDIX B
CODING KEY: ACTIVE PROBLEMS
Al - Definition. A problem statement has been prepared following
consultation with the client, study of the unique character of the
problem, and preliminary analysis of possible methods of solution.
AS - Sea rah. A systematic hunt through the NASA organization and records
Is being conducted to determine if a ready solution to the problem
exists.
A3 - E'ualuation. A ready solution to the problem has apparently been
found and is being tried out.
A4 - holding. A ready solution to the problem has apparently been
found, but is not being implemented.
AS - Engineering. A near-ready solution to the problem has apparently
been found and modifications and/or prototype development is being
planned or conducted.
AB - Dissemination. The problem has been solved with the direct help of
NASA; a documentation package is being prepared for distribution.
A7 - Commercialisation. The problem has been solved with the direct
help of NASA; attempts are now underway to encourage private
enterprise to turn the solution into a commercial product.
A8 - Other. The problem has a unique status not covered by the classifica-
tions above.
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APPENDIX C
CODING KEY: IUCTIVATED PROBLEMS
I1 - The client 'does not have adequate resources or interest at present
to justify BATeam work on the problem.
I2 - The client has solved the problem on his own.
I3 - Searching efforts by the BATeam have not turned up any promising
NASA solutions to the problem.
I4 - Searching efforts by the BATeam have revealed a promising NASA
solution, but no implementation by the client appears like_j at
this time.
I5 - The original problem statement was too broad; it has been rewritten
to more clearly define one or more subproblems and each has been
separately identified.
16 - The problem was dropped because it did not fit the present goals,
priorities, or resources of the BATeam.
I7 - The problem was transferred out of the jurisdiction of the UW-
BATeam.
I8 - Work has been completed on the problem and a NASA transfer has
occurred.
I9 - Work has been completed on the problem and an impact- -a satisfactory
non-NASA solution to the problem- -accomplished with the help of
the BATeam.
I10- Other.
s
r
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University of Wisconsin
1500 Johnson Drive
Madieong Wisconsin 53706
Dr., Borman B. Uuston
	
Jean C. Behrens-Tepper
Principal Investigator
	
Biomedical Engineer
(through 6/78)
	
(started 3/76)
608/263-1550
	
6081263-7799
Dr, John R. Renner*
Co-Principal Investigator
(through 12/77)
608/263-4550
Prof. Melvin P. Siedband
Principal Investigator
(from 7/78)
608/263-1575
Dr. William N- letsnar
Director
608/263-2735
Marjorie Morgan
Secretary
608/263-1575
Everis R. Engstrom
Assistant Scientist
(left 7/78)
608/263-2983
.Jaws C. gouge
Assistant Scientist
606/263-3068
Sakki V. Rudva
Biomedical Engineer
608/263-2526
L. Burke O'Neal
Assistant Scientist
608/263-2921
*Address for Dr. Renner:
Dept. of Family Medicine 6 Practice
777 South Mills Street
Madison, WI 53706
-155-
